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Introduction
Eukaryotic ribosomal RNAs and spliceosomal snRNAs possess numerous post- 
transcriptionaly synthesised 2 ’-0 -ribose-methylated nucleotides and pseudouridines which are 
important to the correct function of ribosome and spliceosome. 2 -O-methylation and 
pseudouridylation of ribosomal RNAs and the RNAPIII-transcribed U6 spliceosomal snRNA 
occur in the nucleolus and are directed by box C/D and box H/ACA modification guide 
RNAs, respectively. By screening a cDNA library of human snRNAs we have identified eight 
novel modification guide RNAs which were predicted to direct 2 -O-methylation and 
pseudouridylation of the RNAPII-transcribed Ul, U2, U4 and U5 spliceosomal snRNAs. We 
have demonstrated that these novel guide RNAs, which indeed function in modification of Sm 
snRNAs, specifically accumulate in the Cajal bodies. Therefore, the new guide RNAs were 
called small Cajal body-specific RNAs (scaRNAs). The Cajal body is an evolutionarily 
conserved nucleoplasmic organelle, the function of which has remained highly elusive for 
more than a century. Our results strongly indicate that at least one function of the Cajal body 
is in post-transcriptional modification of spliceosomal snRNAs
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Cajal (coiled) bodies are conserved sut»^^^ anj.
»«»es that are present in the nucleiopl <» first
•Bal and plant cells. Although function has
described9 nearly 100 years ^ “^ c r ib e  a
remained largely speculative. «  ’ that localize
Bővel class of human small nuclear WNAs ^
specifically to Cajal bodies. The S™  ted or have 
specific RNAs (scaRNAs) « « I J  ^  ^  RNAs 
already been demonstrated to .ribose-methylated
•B site-specific synthesis of * RN* polymer- 
Bucleotides and pseudouridmes m SDiiceosomal
*e 11-transcribed U l, U2 ,U 4  provide
small nuclear RNAs (snRNAs). Cajal body,
strong support for the idea pr0vides the
Ibis mysterious nuclear org ! modification of 
cellular locale for post-transcnptional modinca
spliceosomal snRNAs. „.irWscaRNA/
Keywords: Cajal body/RNA modificaüon/scaK
spliceosomal snRNA/snoRNA
In troduc tion■ "iroaucti  . RNAs
In eukaryotic cells, biogenesis (snRNAs) and
iRNAs, rRNAs, small nuclear RNM (snK^
Bucleolar RNAs (snoRNAs) takes pi a dozen
^be interphase nucleus contains nuciear bod-
•Borphologically distinct subdomains all d ^  synthesis 
which are believed to functio ceHular
Processing, modification or tran P nucleolus,
RNAs, However, with the ^ " of° L  s y n f c *  
'»'hich has long been known as th ise function of
Biaturation of cytoplasmic rRNAs, P (Lamond and 
Buclear bodies remained large y and jollervey,
Eamshaw, 1998; Matera, ,coiled) body is the
200°)- Besides the nucleolus, th‘ J tudied nucleoplas-
Btost prominent and most « tensively«u  ^
■Bic organelle (Matera,
enriched with spliceosomal an „„en ts  of the basal
teins (snRNPs and snoRNPs) and co po growing
transcription machinery. But, d®sP| ecise function of 
list of its molecular components, the precise iu
the Cajal body is still unknown.
The removal of intronic sequences of precursor mRN As 
^  d m aa  is catalysed by the spliceosome, a dynamic 
(pre‘mmv nf five snRNAs I d  numerous protein factors.
^ T i l  yu2f U4 U5 and U6 spliceosomal snRNAs play a The Ul, U2, U4, u j  -  k solicing: they select the
fundament ro e rn^p formation of the active
correct splice s w ill and Luhrmann,
I n "  p S o m i  snRNAs confoih m .„y p o *  
2001). tne p , vnthesized 2'-0 -ribose-methylated
m o t u t o i ^ i o n s  required for foe comer 
dynamic mo SDliceosome. Consistent with this view, 
function ^ 2  snRNA is fundamental for the
S S i y  of foe active spliceosome (Pan and Privea, 1989;
S h e  c syn-
f modified nucleotides in snRNAs has long 
m i  “ eSfoly. * »as been esfobhshed
th™t the nucleolus contains an enormous ™mber °  
™ DW. t tha. d;rect 2'-0 -methylation andpseudoundyla- 
£ r f  S S i  1  Steitz. .997; Kiss, 2001). The
2'-0 -methylation guide snoRNAs carry die 
V terminal C (RUGAUGA) and ^-terminal D (CUGA) 
hoxeT'as well as imperfect internal copies of these 
«  called C' and D'
m^thvlation site sequences preceding the D or u  oox oi 
* e  form a V 2l bp helix with rRNAs (Cavaille
T a l  1996; Kiss-Laszlo et al., 1996). The pseudoundyl- 
ation’ guide snoRNAs fold into a consensus hanpm 
hinge-hairpin-tail’ structure and contain the conserved H 
(ANANNA) and ACA boxes (Balakin et al., 1996; Ganot 
i i  al 1997b) They possess bipartite rRNA recognition 
m o d i w h X  fo m  two shoo helices with ribosomal 
sequences preceding and following the substrate undine S n o t  et al., 1997a; Ni et al., 1997). The conserved box 
C/D and H/ACA motifs play an essential role in snoRNA- 
guided RNA modification reactions “  wel1 “
asIc ile^^o te in Jh av eb een  identified (Kiss, 2001). Most 
Hkely, fibrillarin catalyses the box C/D ^ A - g u i d e d  
2'-0 -methylation reaction (Tollervey et al., 1993, g 
a  al., 2000) and dyskerin is the pseudoundine synthase m 
box H/ACA snoRNPs (Lafontaine et al., 1998, 
Zebarjadian et al., 1999).
2746
Recent evidence indicates that synthesis of the eight 
2'-0-methylated nucleotides and the three pseudouridines 
in the RNA polymerase (pol) Ill-synthesized U6 spliceo- 
somal snRNA takes place in the nucleolus and that it is 
directed by box C/D and H/ACA snoRNAs (Tycowski 
e t al., 1998; Ganot e t a l., 1999). The U6 snRNA, which is 
transcribed in the nucleoplasm, is transported to the 
nucleolus to undergo snoRNA-mediated modification 
(Lange and Gerbi, 2000). Less is known about modifica­
tion of the pol II-transcribed U l, U2, U4 and U5 snRNAs. 
Following nucleoplasmic synthesis, these RNAs are 
transported to the cytoplasm to associate with seven Sm 
proteins and undergo cap hyperméthylation and 3'-end 
formation (Will and Liihrmann, 2001). The newly assem­
bled snRNPs are re-imported to the nucleoplasm, where 
they accumulate in interchromatin granule clusters 
(Lamond and Emshow, 1998; Sleeman and Lamond, 
1999b; Matera, 1999; Lewis and Tollervey, 2000). 
However, a fraction of snRNPs accumulates transiently 
in Cajal bodies (Carmo-Fonseca e t al„  1992; Matera and 
Ward, 1993; Spector 1993; Sleeman and Lamond, 1999a) 
and, under certain conditions, in the nucleolus (Lyon e t al., 
1997; Sleeman and Lamond, 1999a; Lange and Gerbi, 
2000; Yu e t a l., 2001), raising the possibility that these 
nuclear bodies might have a function in the biogenesis, 
trafficking or storage of snRNPs.
Microinjection experiments demonstrated that internal 
modification of the U2 snRNA occurs in the nucleus rather 
than in the cytoplasm of X enopus  oocytes (Yu e t al., 2001). 
The same experiments favoured the nucleolus as the 
intranuclear locale for U2 modification. This conclusion 
was seemingly supported by identification of the U85 box 
C/D-H/ACA composite guide RNA that functions in both 
2'-0-methylation and pseudouridylation of the U5 snRNA 
(Jâdy and Kiss, 2001). In this study, we have characterized 
six novel putative guide RNAs that are predicted to direct 
2'-0-methylation and pseudouridylation of the RNA pol
II-specific Ul, U2, U4 and U5 snRNAs. Unexpectedly, the 
new guide RNAs as well as the previously characterized 
U85 RNA accumulate specifically in Cajal bodies and 
therefore they comprise a novel class of small nuclear 
RNAs, called the small Cajal body-specific RNAs 
(scaRNAs). These results indicate that the Cajal body 
functions in the post-transcriptional modification of pol II- 
specific spliceosomal snRNAs.
Resu lts
Iden tifica tion  o f nove l com posite  box C /D -H /ACA RNAs
We have recently characterized an unusual modification 
guide RNA, the U85 RNA, which functions both in 2 '-0 -  
methylation and pseudouridylation of the U5 snRNA (Jâdy 
and Kiss, 2001). The U85 RNA is composed of a box C/D 
and a box H/ACA snoRNA-like domain (Figure 1), and is 
associated with both fibrillarin and Garlp, which are 
specific protein components of box C/D and box H/ACA 
snoRNPs, respectively. To identify novel box C/D-H/ 
ACA composite RNAs, human HeLa RNAs were 
immunoprecipitated with anti-fibrillarin antibody and 
size-fractionated on a sequencing gel. RNAs migrating 
between labelled DNA markers of 234 and 368 nucleo­
tides were recovered and used as a template for cDNA
synthesis (Kiss-Lâszlo e t al., 1996). In brief, the 5' sbA 
3 ' termini of the purified RNAs were tagged with 3 
phosphorylated oligonucleotide by using T4 RNA ligase- 
The double-tagged RNAs were amplified by RT-PCR and 
cloned into a plasmid vector. Sequence analyses of several 
individual clones identified three putative snoRNAs- 
called U87, U88 and U89, which possessed C and D box 
motifs, but otherwise lacked significant similarity to any 
known RNAs (Figure 1). Northern blot analyses confirmed 
that the new RNAs are expressed in HeLa cells (data not 
shown). The genomic copies of the new RNAs were found 
within introns of putative protein-coding genes, indicating 
that they are generated by intron processing (see legend to 
Figure 1).
A computer-aided structural analysis revealed that the 
U87, U88 and U89 RNAs can be folded into a two- 
dimensional structure that is highly reminiscent of the 
architecture of the U85 box C/D-H/ACA RNA character­
ized previously (Figure 1). In each RNA, the 5'- and 
3'-terminal regions carrying the C and D boxes can form3 
long stem structure, whereas the middle region folds into 
the consensus ‘hairpin-hinge-hairpin-taiT structure of 
box H/ACA snoRNAs. Moreover, the single-stranded 
hinge and tail regions carry potential box H and ACA 
sequences, respectively. To assess whether the novel 
putative box C/D-H/ACA snoRNAs are associated with 
both box C/D and H/ACA snoRNP proteins, immunopré­
cipitation experiments were performed from a human 
HeLa cell extract using anti-fibrillarin and anti-GARl 
antibodies (Figure 2A). RNase A/Tl protection analyse® 
demonstrated that the U87, U88 and U89 RNAs, like the 
U85 box C/D-H/ACA RNA, were precipitated by both 
antibodies. Please notice that immunological properties of 
the human U90 and U92 RNPs, although tested in this 
experiment, will be discussed later. As expected, the Ul9 
box H/ACA snoRNP was precipitated only by the anti- 
GARl and the U3 box C/D snoRNP was recognized only 
by the anti-fibrillarin antibody and neither of the two 
antibodies reacted with the U4 spliceosomal snRNP. We 
concluded that the newly identified U87, U88 and U89 
RNAs, together with U85, comprise a new group of 
snoRNAs that are composed of a box C/D and a H/ACA 
snoRNA domain, and are associated with both box CiO  
and box H/ACA snoRNP proteins.
Box C /D -H /ACA RNAs can d irect post- 
transcrip tiona l m odifica tion  o f p o l II-specific  spliceosom al snRNAs
Examination of the sequences of the new box C/D-H/ 
ACA RNAs showed that they lack significant sequence 
complementarity to rRNA sequences, making it unlikely 
that they function in rRNA modification. We have recently 
demonstrated that the human U85 box C/D-H/ACA RNA 
directs 2'-0-methylation of the C45 and pseudouridylation 
of the U46 residues in the U5 spliceosomal snRNA 
(Figure 3). We therefore investigated whether the novel 
box C/D-H/ACA RNAs could also function in snRNA 
modification. We found that sequences preceding the D 
and the putative D' boxes of the U87 RNA could, in 
principle, direct 2'-0-methylation of the A65 and U41 
residues in the U4 and U5 snRNAs, respectively (Figure 3)- 
Indeed, both of these nucleotides are known to be 2'-O ’ 
methylated in vertebrate U4 and U5 snRNAs (Reddy and
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'«Pies of ¿ e  U85 and U89 snoRNAs are in the encoded within the ninth and twelfth intrtms of a putatrve protem-eod.ng gene
^ te in  (U75511) genes, respectively. The U87 and U88 snoRNA 
(BC00006l).
5“sch, 1988; Massenet e t  a l., 1998). Like U87, the U88 
Was a S^0 predicted to function in 2 '-0 -methylation of 
he U41 residue in the U5 snRNA, although apart from the 
Putative U5 recognition elements, the two RNAs show no 
Sl8nificant sequence similarity. Likewise, the U89 RNA 
and the previously characterized U85 RNA also seem to 
share a common function, namely directing pseudouridyl- 
a9on of the U46 residue in the U5 snRNA. Again, the U85 
and U89 RNAs, disregarding the short U5 recognition 
HPutifs, possess no overall sequence similarity. Our 
observations strongly suggest that the box C/D-H/ACA 
NAs function in the modification of pol Il-specific 
sPüceosomal snRNAs and that synthesis of 2 '-0 -methyl- 
ated nucleotides and pseudouridines in snRNAs is 
requently achieved by functionally redundant snoRNPs.
U 8 5  R N A  a c c u m u la te s  in  C a ja l b o d ie s
0 fur, all small RNAs carrying the box C/D or H/ACA 
JPotifs have been found to accumulate in the nucleolus 
^mith and Steitz, 1997; Tollervey and Kiss, 1997; 
Einstein and Steitz, 1999). In fact, the conserved C/D 
and H/ACA boxes are the key determinants of the
nucleolar targeting of snoRNAs (Lange e t a l., 1998; 
Samarsky e t a l., 1998; Narayanan e t  a l., 1999a, b). 
Therefore, the U85, U87, U88 and U89 box C/D-H/ACA 
RNAs were assumed to accumulate in the nucleolus. 
However, during exploration of cDNA libraries of human 
nucleoplasmic or nucleolar RNAs, we noticed that partial 
or full-length cDNAs of the U85 RNA frequently appeared 
in the nucleoplasmic library, but were not found in the 
nucleolar one (our unpublished results). To test the 
significance of this unexpected observation, human HeLa 
cells were fractionated into nuclear, nucleoplasmic, 
nucleolar and cytoplasmic fractions, and distribution of 
the U85 RNA was determined by RNase A/Tl mapping 
(Figure 2B). To our surprise, the U85 RNA was found 
mostly in the nucleoplasmic fraction. As expected, the 
U19 box H/ACA and the U3 box C/D snoRNAs showed a 
predominantly nucleolar accumulation, while the U4 
spliceosomal snRNA appeared mostly in the nucleoplas­
mic fraction.
The fascinating discovery that the U85 box C/D-H/ 
ACA RNA co-purifies with the nucleoplasmic fraction of 
HeLa cells prompted us to examine further the localization
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Fig. 2. Characterization of the novel RNAs. (A) Immunoprécipitation of human snoRNPs. An extract prepared from HeLa cells was incubated with 
protein A-Sepharose saturated with anti-fibrillarin (oc-Fib) or anti-GARl (a-Gar) antibodies. Upon collection of Sepharose beads by centrifugation. 
RNAs were recovered by proteinase K treatment and phenol extraction. Distribution of RNAs was determined by RNase A/Tl mapping using 
sequence-specific antisense RNA probes as indicated on the right. Control mappings performed with E.coli tRNA (C) or RNAs obtained from the 
HeLa cell extract (E) are also shown. Mock represents control reaction with protein A-Sepharose alone. Lane M, size markers (terminally labelled 
HoeIII- and Ta^I-digested pBR322). (B) Intracellular localization. RNA isolated either from HeLa cells (T), or from nuclear (Nu), nucleoplasmic 
(Np), nucleolar (No) or cytoplasmic (Cy) fractions of HeLa cells were analysed by RNase A/Tl mapping using sequence-specific RNA probes- 
Lane C represents control mapping with E.coli tRNA.
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of this RNA using fluorescent in  situ  hybridization 
microscopy (Figure 4A). Probing of HeLa cells with a 
U85-specific fluorescent antisense RNA revealed that the 
U85 RNA, instead of showing a uniform distribution, 
localizes to a few sharp, dot-like structures in the 
nucleoplasm. Since this distribution pattern of U85 was 
highly reminiscent of that of Cajal bodies (Matera, 1998; 
Gall, 2000), the cells were also stained with an antibody 
directed against p80 coilin, a protein marker of the Cajal 
body (Andrade e t  a l., 1991). The U85 RNA and p80 coilin 
co-localized perfectly, demonstrating that the nucleoplas­
mic dots revealed by the U85 probe correspond to Cajal 
bodies.
To exclude the possibility that a fraction of U85 RNA 
accumulates outside the Cajal bodies, we investigated the 
distribution of U85 RNA after overproduction in HeLa 
cells. To this end, the human U85 RNA gene was inserted 
into the second intron of the human [i-globin gene, which 
had been placed under the control of the cytomegalovirus 
(CMV) promoter (Figure 4B). The human U85 RNA was 
efficiently and correctly expressed in human HeLa and 
simian COS-7 cells transfected with the pCMV-globin- 
U85 expression construct (Jady and Kiss, 2001; data not 
shown). The in s itu  labelling patterns of the U85 RNA 
probe and the p80 coilin antibody were compared in 
transfected HeLa cells (Figure 4B). Upon hybridization 
with the U85 fluorescent probe, a strong signal was 
observed in cells that overproduced the U85 RNA. With
the same exposure time, endogenous U85 RNA was not 
detected in the nucleus of non-transfected cells (Figure 4B. 
circled). Double labelling with anti-p80 coilin clearly 
showed that even after its overproduction, the U85 RNA 
accumulated exclusively in Cajal bodies. Since RNase A/ 
T1 mappings failed to detect 5'- and/or 3'-extended 
precursors of U85 (Jady and Kiss, 2001; data not 
shown), we concluded that the U85-specific sequences 
accumulating in the Cajal bodies represent fully processed 
U85 RNAs. As a control, the human mgU6-53 box CIV  
snoRNA, which directs 2'-0-methylation of the RNA pol
Ill-transcribed U6 spliceosomal snRNA (Ganot e t a l-  
1999), was also overproduced in HeLa cells. In situ  
hybridization revealed that the mgU6-53 snoRNA accu­
mulated in large areas of the nucleus, as well as in small 
dots. It clearly co-localized with a green fluorescent 
protein (GFP)-tagged version of human fibrillarin, an 
abundant nucleolar protein that is also present in Cajal 
bodies (Gall, 2000). Therefore, the mgU6-53 snoRNA 
accumulated mainly in the nucleolus of transfected cells 
and, to a smaller extent, in the Cajal bodies, as confirmed 
by staining with the anti-coilin antibody. This observation 
was fully consistent with our previous cell fractionation 
experiments, in which the mgU6-53 snoRNA was 
localized mainly to the nucleolar fraction of human 
HeLa cells (Ganot e t a l., 1999). In summary, we concluded 
that in both transfected and non-transfected HeLa cells, 
mature U85 RNA localizes specifically to Cajal bodies.
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U85 G^ C-'rs
«0-AAUCUl?’ ^UAAGGG(N)7ibôxÏÏl
mi l l  m i n i
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U89 G^ -rza
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^UAAUGGUUUCUAG-309
US 41
OTJCCUÛUUACUAA-S»
I I I II I I I I I II
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U87
*^hoxD'
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«f-AUUGAAAACUU 7t
I I I II I I I I I I
^PlJAACUUUUGAAJSi
U87
box D
1/5 4.1
37-GCCUUUUACUA-47
11 1 l 11111M
/^UGGAAAAUGGU-M
U88
£  '-''b o x  D'
^  Potential base-pairing interactions between human 
lilt methVlation (closed circle) or pseudouridylation CV) 
Ke Contains of the U85 and U89 RNAs are schematically
box C/D-H/ACA RNAs and spliceosomal snRNAs. Nucleotides predicted to be selected for 
in the human snRNAs are indicated. The 5'-terminal hairpins of the box H/ACA snoRNA- 
represented. Positions of the H, D and D' boxes are indicated.
® ° *  C /D -H /A C A  R N A s  r e s id e  in  C a ja l b o d ie s
e then investigated the subcellular localization of the 
newly discovered box C/D-H/ACA RNAs. Cell fractiona- 
experiments revealed that the U87, U88 and U89 
NAs, like U85, accumulate mostly in the nucleoplasmic 
“action of HeLa cells (Figure 2B). To facilitate in  situ  
l0calization, the U87, U88 and U89 RNAs were over­
dressed in HeLa and COS-7 cells using the pCMV- 
jjohin expression vector as described for the U85 RNA.
a^se A/Tl mappings demonstrated that the U87, U88, 
and U89 RNAs were efficiently and faithfully expressed in 
“ansfected HeLa and COS-7 cells (data not shown).
To determine the localization of the overproduced U87, 
U8s and U89 RNAs in HeLa cells, double labelling 
Experiments were carried out with sequence-specific 
nuorescent RNA (U87, U89) or oligonucleotide (U88) 
pr°bes and the anti-p80 coilin antibody (Figure 5). For 
eaçh RNA, a perfect co-localization was observed with 
c°*lin, demonstrating that the overexpressed RNAs accu­
rate in the Cajal bodies of HeLa cells. The same results 
'Vere obtained by in  s itu  localization of the transiently 
p^ressed human U87, U88 and U89 RNAs in COS-7 cells 
a^ta not shown). Moreover, probing of non-transfected 
f*eLa cells with the U88 probe specifically stained Cajal 
. °d>es, indicating that endogenous U88 RNA also resides 
Î® this nuclear organelle. Our results demonstrate that the 
hüman U85, U87, U88 and U89 box C/D-H/ACA RNAs 
Eornprise a novel class of cellular RNAs that localize 
specifically to the Cajal body. The new group of snRNAs 
a^s collectively named small Cajal body-specific RNAs 
(scaRNAs).
R N A s  im p l ic a te d  in  m o d i f ic a t io n  o f  
b o / l l - s p e c i f ic  s p l ic e o s o m a l s n R N A s  re s id e  in  
2*1*1  b o d ie s
ae results presented thus far indicate that scaRNAs 
’fecting modification of snRNAs are composed of a box 
C/D and a H/ACA snoRNA domain. In cDNA libraries 
^ human fibrillarin- and Garlp-associated snoRNAs, we 
J*ave identified three novel RNAs, called U90, U91 and 
U92 (Figure 6A). The U90 and U91 RNAs possess die 
characteristic core motif of box C/D snoRNAs, which 
deludes the conserved C and D boxes and a short 5,
3'-terminal helix. Immunoprécipitation experiments demon­
strated that the U90 (Figure 2A) and U91 (data not shown) 
RNAs represent bona fide fibrillarin-associated box C/D 
snoRNAs and are not associated with the Garl box H/ 
AC A snoRNP protein. The U90 and U91 RNAs also carry 
putative C' and D' boxes, which are juxtaposed by short 
internal helices. This indicates that they probably function 
in RNA 2'-0-methylation, since positioning the C' and D' 
boxes in close proximity to each other is essential for the 
box D'-dependent 2'-0-methylation reaction (Kiss-Laszlo 
e t a l., 1998). Indeed, we found that sequences preceding 
the D' boxes of U90 and U91 can position the A70 and C8 
residues in the human U1 and U4 snRNAs, respectively, 
for 2 '-0 -methylation (Figure 6A). Both of these nucleo­
tides are in fact 2'-<9-methylated in mammalian U1 and U4 
snRNAs (Reddy and Busch, 1988). In contrast to U90 and 
U91, the human U92 RNA lacks C and D boxes, but it 
folds into the consensus ‘hairpin-hinge-hairpin-tail’ 
structure of box H/ACA snoRNAs (Figure 6A). The U92 
RNA binds the Garl, but not the fibrillarin snoRNP protein 
(Figure 3A), demonstrating that it is an authentic box H/ 
ACA snoRNA. We noticed that the U92 box H/ACA 
RNA, in theory, is capable of directing pseurouridylation 
of the U44 residue in the U2 snRNA (Figure 6A). During 
the course of this study, a large-scale characterization 
of mouse non-coding nuclear RNAs revealed partial 
sequences of the apparent mouse orthologues of the 
human U91 (MBII-119) and U92 (MBI-57) RNAs, showing 
that these putative snRNA modification guide RNAs are 
conserved in mammalian cells (Hiittenhofer e t  a i ,  2001).
To assess whether all guide RNAs implicated in 
modification of pol Il-specific snRNAs accumulate in 
Cajal bodies, we investigated the intracellular localization 
of the newly identified U90, U91 and U92 RNAs. 
Encouragingly, cell fractionation experiments revealed a 
nucleoplasmic localization for the U90 box C/D and the 
U92 box H/ACA RNAs (Figure 2B). Next, probing of 
HeLa cells with fluorescent antisense probes specific for 
the U91 and U92 RNAs resulted in strongly staining dots 
in the nucleoplasm (Figure 6B, U91endo and U92endo). 
Double labelling with anti-p80 coilin antibody showed 
that the dots highlighted by the U91- and U92-specific 
probes corresponded to Cajal bodies. The U92 RNA,
2750
A RNA Coilin
U85
endo
B pCMV-globin
Q O
mgU6-53
23Q S 0E 3
Fig. 4. Human U85 box C/D-H/ACA RNA localizes to Cajal bodies. (A) In situ localization of the endogenous U85 RNA. Human HeLa cells were 
probed with a fluorescent antisense RNA complementary to the human U85 RNA from position 1 to 76 and with an antibody directed against p$® 
coilin as indicated above the panels. The merged image shows that the U85 RNA co-localizes with p80 coilin. Scale bar, 10 pm. (B) In situ localiZ' 
ation of transiently overexpressed U85 and mgU6-53 RNAs in HeLa cells. The schematic structure of the pCMV-globin expression construct is 
shown. The exons (El, E2 and E3) and the polyadenylation site (PA) of the human P-globin gene are indicated. The transcription initiation site of the 
cytomegalovirus promoter (CMV) is indicated. The coding regions of the human U85 and mgU6-53 RNAs in the second intron of the globin gene are 
represented by an open arrow. Relevant restriction sites are shown (H, //indill; C, C/oI; X, Xhol). The pCMV-globin-mgU6-53 plasmid was co-trans- 
fected with an expression construct producing a GFP-tagged version of the human fibrillarin protein. The overexpressed U85 and mgU6-53 RNAS 
were visualized by sequence-specific fluorescent RNA probes and Cajal bodies were specifically stained by anti-p80 coilin. Arrows indicate nucleolar 
stained structures enriched in mgU6-53 and fibrillarin. Arrowheads point to Cajal bodies, which clearly contain mgU6-53, fibrillarin and p80 coilin- 
The contour of the nucleus of a non-transfected HeLa cell is highlighted.
probably due to its low abundance, was not directly 
detectable in HeLa cells. Therefore, localization of this 
RNA and also the U90 RNA was investigated in HeLa 
cells transfected with pCMV-globin constructs expressing 
the U92 and U90 RNAs. U90 and U92 were correctly and 
efficiently expressed in transfected HeLa cells (data not 
shown) and, as in  situ  localization experiments demon-
strated, localized specifically to Cajal bodies (Figure 6B. 
U90 and U92). We concluded that 2'-0-methylation and 
pseudouridylation guide RNAs that function in post- 
transcriptional modification of the RNA pol Il-transcribed 
spliceosomal snRNAs, irrespective of their box elements, 
associated proteins and molecular sizes, specifically and 
exclusively accumulate in Cajal bodies.
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ACA pm  SUU localiza,ion human U87, U88 and U89 box C/D-H/ 
CJ!pre Human U87, U88 and U89 RNAs were transiently over
f], .ssed *n HeLa cells using the pCMV-globin expression construct, 
^ in trac e llu la r  distribution of the overproduced U87, U88 and U89 
*®ves« ** WC" as tflc endogenous HeLa U88 RNA (U88endo) was 
viSu ]!®ated by fluorescent in situ hybridization. Cajal bodies were 
tzed by staining with anti-p80 coilin antibody. For other details, 
the legend to Figure 4.
Discussion
f^ e interphase nucleus has an intricate structural and 
. nctional organization. It contains many distinct sub- 
0rnains, also known as nuclear bodies, which represent 
P^ecific and dynamic assemblies of protein and RNA 
actors involved in various aspects of nuclear gene 
exPtession. The Cajal body is a prominent and extensively 
studied nuclear organelle of unknown function (Bohmann 
p a^ -> 1995; Lamond and Eamshaw, 1998; Matera, 1999; 
'¡'all, 2000; Lewis and Tollervey, 2000). Understanding of 
k function of the Cajal body has been hampered largely 
y the fact that all its known components are also 
lstributed in the nucleoplasm or, frequently, they con- 
Centrate in other nuclear bodies. Thus far, the p80 coilin 
autoantigene is the only unambiguous molecular marker 
ur the Cajal body, although most of this protein is 
, ispersed in the nucleoplasm. The Cajal body is enriched 
ln sPliceosomal snRNPs and nucleolar snoRNPs, but lacks 
’URNAs and rRNAs, indicating that it does not function in 
^NA splicing or rRNA maturation (Bohmann e t  a l., 
^5). Several lines of evidence indicate that there is a flux 
uf newly synthesized snRNPs and snoRNPs through the 
ajal body, leading to the idea that the Cajal body may 
Auction in the biogenesis and/or transport of snRNPs and 
SnoRNPs (Sleeman and Lamond, 1999a; Gall, 2000).
to this report, we have described a novel class of human 
Small nuclear RNAs, scaRNAs, which accumulate specif- 
Jually jn Cajal bodies. Apart from the fact that scaRNAs 
fuquently contain both box C/D and H/ACA snoRNA 
uuiains, they are structurally indistinguishable from the 
canonical box C/D and box H/ACA snoRNAs (Figures 1 
and 6A). Depending on their box elements, scaRNAs are 
associated with characteristic protein components of the
nucleolar box C/D and H/ACA snoRNPs (Figure 2A). 
In s itu  hybridization experiments demonstrated that the 
U85 and U87-U92 scaRNAs localize specifically and 
exclusively to Cajal bodies. The scaRNAs are not 
detectable outside the Cajal bodies, even after massive 
overproduction in HeLa and COS-7 cells (Figures 4-6). 
Therefore, the U85 and U87-U92 scaRNAs represent the 
first molecular markers of the Cajal body, which partition 
exclusively to this nuclear body.
The exclusive localization of scaRNAs to the Cajal 
body suggests that they function in this nuclear organelle. 
We have demonstrated previously that the U85 scaRNA 
functions as a guide RNA in 2'-0-methylation and 
pseudouridylation of the U5 spliceosomal snRNA (Jâdy 
and Kiss, 2001). Intriguingly, the newly discovered 
scaRNAs are also predicted to direct 2'-0-methylation 
and/or pseudouridylation of the Ul, U2, U4 and U5 
snRNAs (Figures 3 and 6A). We propose that post- 
transcriptional modification of pol II-specific spliceosomal 
snRNAs is directed by a novel class of guide RNAs that 
reside in the Cajal body. Mammalian Ul, U2, U4 and U5 
snRNAs together carry 13 2'-0-methyl groups and 21 
pseudouridine residues (Reddy and Busch, 1988). In this 
study, seven scaRNAs have been connected with the 
synthesis of five 2 '-0 -methylated nucleotides (U85, U87, 
U88, U90 and U91) and two pseudouridine residues (U85, 
U89 and U92) in pol II-specific snRNAs. Currently, we 
have identified another box H/ACA scaRNA, which is 
predicted to direct pseudouridylation of the U2 snRNA at 
the U54 position (our unpublished data). In a previous 
study, two box C/D (MB II-19 and MBII-382) and two box 
H/ACA (MBI-57 and MBI-125) RNAs have been impli­
cated in the synthesis of three 2 '-0 -methylated nucleotides 
and two pseudouridines in the U2 snRNA (Hiittenhofer 
e t a l., 2001). Unfortunately, the cellular localization of 
these RNAs has not been explored. Nevertheless, thus far, 
12 putative guide scaRNAs have been linked with the 
synthesis of 1 2  2 '-0 -methylated nucleotides and two 
pseudouridines in the Ul, U2, U4 and U5 snRNAs. We can 
envisage that the synthesis of most, if not all, 2'-O -  
methylated nucleotides and pseudouridines in pol II- 
specific spliceosomal snRNAs is directed by scaRNAs.
So far, the Cajal body is the only common nuclear locale 
where both spliceosomal snRNAs and their modification 
guide RNAs have been demonstrated to accumulate. 
Therefore, it seems unlikely that the Cajal body is only a 
storage place for scaRNAs, and scaRNA-directed snRNA 
modification occurs in another nuclear compartment. 
Previously, the nucleolus has been implicated in post- 
transcriptional modification of both the RNA pol Ill- 
transcribed U6 (Tycowski e t a l., 1998; Ganot e t a l., 1999; 
Lange and Gerbi, 2000) and the pol II-specific U2 
spliceosomal snRNAs (Yu e t  a l., 2001). The idea that 
modification of the U6 snRNA occurs within the nucleolus 
is supported by the fact that all tra n s-acting factors, most 
likely snoRNPs, that accomplish the synthesis of the eight 
2'-0 -methylated nucleotides and the three pseudouridines 
of the U6 snRNA are present and are functionally active in 
the nucleolus (Tycowski e t  a l., 1998; Ganot e t a l., 1999; 
Figure 4B). Upon microinjection into the nucleoplasm of 
X en o p u s oocyte, the U6 snRNA appears transiently in the 
nucleolus, suggesting that it transits through the nucleolus 
to undergo snoRNA-directed modification (Lange and
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Fig. 6. Localization of box C/D and H/ACA RNAs predicted to function in modification of pol Il-specific spliceosomal snRNAs. (A) Structure and 
function of human U90, U91 box C/D and U92 box H/ACA RNAs. The conserved box C/D and the potential C ' and D' motifs of the U90 and U9l 
RNAs are indicated. Inverted arrows under the sequences of U90 and U91 indicate nucleotides predicted to form terminal and internal helices. The 
predicted two-dimensional structure of the U92 RNA was obtained by computer folding. The H and ACA sequence motifs are boxed. Predicted base- 
pairing interactions of the U90, U91 and U92 RNAs with the UI, U4 and U2 snRNAs, respectively, are indicated. The 2'-0-methylated A70 and C8 
nucleotides in the selected sequences of the Ul and U4 snRNAs are indicated by dots. The pseudouridine residue OF) at position 44 in the human U2 
snRNA is marked. (B) Localization of human U90, U91 and U92 RNAs in HeLa cells. Overexpressed (U90 and U92) and endogenous (U91endo and 
U92endo) modification guide RNAs were visualized with sequence-specific fluorescent probes. For other details, see legends to Figures 4 and 5.
Gerbi, 2000). Although maturation of the RNA pol II- 
synthesized Ul, U2, U4 and U5 snRNAs includes a 
cytoplasmic phase (Will and Ltihrmann, 2001), internal 
modification of the pol II-transcribed U2 snRNA occurs 
in the nucleus (Yu e t a l., 2001). In X en o p u s oocytes, 
modification of the U2 snRNA was found to require an
intact Sm motif (Yu e t  a l., 2001). Lack of a functional Sm 
site could be complemented by addition of a S'.S'-terminal 
box C/D snoRNA core structure. As the resulting chimeric 
U2-box C/D RNA was efficiently modified and il 
accumulated in the nucleolus, it was suggested that the 
nucleolus provides the cellular locale for U2 modification-
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However, knowing that box C/D snoRNAs appear 
transiently in Cajal bodies before accumulating in the 
ancleolus (Samarsky e t al., 1998; Narayanan e t al., 1999b; 
see also Figure 4B), these experiments could not rule out 
|^e possibility that the modification of the chimeric 
H2-box C/D RNA happened in Cajal bodies (Yu e t al., 
2001). Previously, we found that U2 snRNA sequences 
synthesized within the nucleolus by RNA pol I were not 
modified, but U6-specific sequences expressed under the 
^me conditions were correctly and efficiently modified 
(Canot e t al., 1999). This indicated that modification of the 
H2 and probably other pol II-specific snRNAs, in contrast
G6, occurs outside the nucleolus. Consistently, in situ  
hybridization experiments failed to provide any evidence 
supporting accumulation of the U85 and U87-U92 guide 
^ A s  in the nucleolus, while the mgU6-53 box C/D 
Sr>oRNA directing 2,-0-methylation of the U6 snRNA 
accumulated mostly in the nucleolus (Figures 4-6).
A notion that the Cajal body provides the cellular locale 
'0r modification of pol II-specific snRNAs raises the 
Question of whether the scaRNA-guided modification of 
snRNAs occurs before or after the cytoplasmic assembly 
°f Sm snRNPs. Upon microinjection into the cytoplasm of 
Xenopus oocytes, in  vitro  synthesized U2 RNA accumu- 
ates in the nucleoplasm and undergoes pseudouridylation 
2'-0-methylation (Yu et al., 2001). This demonstrates 
®at modification of the U2 snRNA can occur in the 
"ascent Sm snRNP after its re-entry into the nucleus, 
•"deed, the newly made snRNPs accumulate transiently in 
^ajal bodies after re-entering the nucleus (Carvalho et al., 
l9" ;  Sleeman and Lamond, 1999a). However, we cannot 
fxclude that at least some modifications are introduced 
'"to the U2 snRNA before its export to the cytoplasm, 
s'"ce nascent precursor U2 snRNAs have also been 
¡^Ported to appear in Cajal bodies (Smith and Lawrence, 
2000) .
Since scaRNAs possess all those elements necessary 
""d sufficient to direct the nucleolar accumulation of box 
and H/ACA snoRNAs (reviewed in Tollervey and 
Ktss, 19 9 7 ; Weinstein and Steitz, 1999), the molecular 
"^chartism directing scaRNAs to the Cajal body, rather 
t"an to the nucleolus, is conjectural. The U85, U87, U88 
""d U89 scaRNAs are composed of a box C/D and a box 
H/ACA snoRNA domain. Therefore, these RNAs, in 
^ e°ry, possess two independent nucleolar localization 
?'8nals, any of which should be able to direct these RNAs 
'"to the nucleolus. Apparently this is not the case. Since 
P°x C/D snoRNAs are known to transit through Cajal 
k°dies before accumulating in the nucleolus (Samarsky 
et <>l, 1998; Narayanan e t al., 1999b), we can hypothesize 
^ at the C/D motif targets the box C/D (U90, U91) and the 
c°mposite box C/D-H/ACA (U85, U87, U88 and U89) 
^aRNAs to the Cajal body, where a putative retention 
[actor inhibits the nucleolar export of these RNAs. 
However, identification of the U92 box H/ACA scaRNA 
clearly demonstrates that RNAs lacking C and D boxes can 
also accumulate in the Cajal body (Figure 6B). Whether 
jhe Cajal body-specific accumulation of the box C/D and 
k°x H/ACA scaRNAs is supported by two different 
Mechanisms remains uncertain.
la summary, demonstration that the molecular machin- 
ery mediating the 2'-0-methylation and pseudouridylation
the RNA pol II-transcribed U l, U2, U4 and U5
spliceosomal snRNAs is sequestered into the Cajal body 
sheds new light on the cellular function of this mysterious 
nucleoplasmic organelle and reveals new details of the 
spatial organization of the biogenesis of spliceosomal 
snRNPs. In the future, dissection of the cw-acting elements 
and identification of the trans-acting factors responsible 
for the Cajal body-specific accumulation of scaRNAs 
will provide us with new insights into the molecular 
mechanism underlying the nuclear compartmentalization 
of eukaryotic RNA biogenesis.
Materials and methods
General procedures
Unless indicated otherwise, all techniques used for manipulating RNA, 
DNA and oligonucleotides were according to Sambrook et at. (1989). The 
following oligonucleotides were used in this study: 1, AATAAAGCGG- 
CCGCGGATCCAA; 2, TTGGATCCGCGGCCGCTTTAT; 3, ATAAT- 
CGATGGAAGGTGTTTGTTATC; 4, ATACTCGAGTTTCACTCAC- 
TTCTTTC; 5, ATAATCGATAGTCCCACTCCACTCCTGTG; 6, ATA- 
CTCGAGGGTGACCAAACCTTTTACCC; 7, ATAATCGATACATC- 
AGTGAATACCTTCTG; 8, ATACTCGAGAACATCAGGACTCCTT- 
ATGT; 9, ATAATCGATCTCAGCCCAGCCCCTAGGGC; 10, ATAC- 
TCGAGCCTGGCCCTGTCCTT ACC AC; 11, ATAATCGATTCTCCA- 
TAACAAGCATTAAT; 12, ATACTCGAGTAACTAATAAGTITT- 
ACTCT; 13, ATAATCGATTGGGAGGCTGATACACAAATTGG; 14, 
ATACTCGAGATCTGTCTGCCCCGTATCTG; 15, ATAATCGATAT- 
CTCCCAATGGTACCTGAAC; 16, ATACTCGAGTCAGTCATGAT- 
GGAATGGGG; 17, GCCACATGATGATATCAAGGC; 18, GTAAT- 
ACGACTCACTATAGGGGACCTTTAACAGGCCAAAGG: 19, TAA- 
GTCATGTGTATGGGATC; 20, AATACGACTCACTATAGGGGGT- 
TTGTTGGATACTCGTC; 21, AGATCTGAAATCTTAGTGGT; 22, A; 
ATACGACTCACTATAGGGGGCAGCACCAGAAATGAAGGC: 23, 
GCTGATATTGGAGTGCATCTG; 24, AATACGACTCACTATAGG- 
GGGGTGCCAGGCTAGTTAGGTG; 25, TGGGAGGCTGATACACA- 
AATTGG; 26, AAT ACGACTC ACT AT AGGGGGG ATCTGTCTGCC- 
CCGTATCTG; 27, TCCCAATGATGAGTTGCC; 28, AATACGACT- 
CACTATAGGGGGACCCCTCAGATCTTCATGTG: 29, CT*GGGA- 
TGCCGGGAGGGGAT*CTGAGGACT*CAGACCTTTTACCATT*C; 
30, CGGCCT*CAGTCAGTTGT*CAGAAGATACT*CCAT«CACC- 
TGGTTC. Sequences corresponding to the T7 RNA polymerase 
promoter are underlined. Amino-allyl-modified T residues are marked 
by asterisks.
Plasmid construction
Synthesis and cloning of cDNAs of human scaRNAs were performed as 
described by Kiss-Laszlo et at. (1996). RNAs immunoprecipitated from a 
HeLa cell extract by anti-fibrillarin or anti-GARl antibodies were size- 
fractionated on a 6% sequencing gel. The appropriate RNA fractions were 
recovered and incubated with an excess of 5'-end-phosphorylated 
oligonucleotide 1 in the presence of T4 RNA ligase. The ligation product 
was used as a template for cDNA synthesis by using oligonucleotide 2 as 
a primer and AMV reverse transcriptase. The resulting first strand cDNA 
was used as a template for PCR amplification by Vent polymerase using 
oligonucleotides 1 and 2 as primers. The amplified DNA was digested by 
BamHl and inserted into the same site in pBluescribe (Stratagene).
To obtain pCMV-globin, the //mdlll-EcoRI fragment of the human 
^-globin gene carrying three artificial restriction sites (Clal, Mlul and 
Xhol) in its second intron was excised from the pGCxm expression vector 
(Kiss and Filipowicz, 1995) and inserted into the same sites of the 
pcDNA3 vector (Invitrogen). Removal of the EcoRI-Xfcal fragment of 
the resultant pcDNA3-globin construct yielded pCMV-globin. DNA 
fragments containing the coding genes of the human U85, U87, U88, 
U89, U90 and U92 scaRNAs were PCR amplified using human genomic 
DNA as a template, and oligonucleotides 3/4,5/6,7/8,9/10,11/12 and 13/ 
14 as primers, respectively. The amplified DNAs were digested with Clal 
and Xhol and were inserted into the same sites of pCMV-globin. 
Likewise, a fragment of the human genome encoding the mgU6-53 
snoRNA was amplified (oligonucleotides 15 and 16), and cloned into the 
Clal-Xhol sites of pCMV-globin. Transfection of human HeLa and 
COS-7 cells was performed as described before, except that the 
transfection reagent Fugene (Roche) was used (Kiss and Filipowicz, 
1995).
RNA extraction and analysis
Guanidinium thiocyanate/phenol-chloroform extraction was used to 
isolate RNA from human HeLa and simian COS-7 cells, and from the 
nuclear, nucleolar and nucleoplasmic fractions of HeLa cells (Goodall 
et al., 1990). RNAs were extracted from the cytoplasmic fraction of HeLa 
cells and the Sepharose beads of immunoprécipitation reactions by 
proteinase K treatment followed by phenol-chloroform extraction. RNase 
A/Tl protection assays were performed as described (Goodall et a i, 
1990). Synthesis of antisense RNA probes for mapping of U4, U3 and 
U19 RNAs have been described (Ganot et al., 1997b). For synthesis of 
sequence-specific probes for the U85, U87, U88, U89, U90, U91 and U92 
scaRNAs, the appropriate pCMV-globin expression construct was 
linearized by 7/mdIII and used as template for transcription by the SP6 
RNA polymerase. After synthesis, each RNA probe was purified on a 6% 
sequencing gel.
Immunoprécipitation and cell fractionation
Human HeLa S3 cells were grown in a suspension culture in Joklik’s 
modified Eagle’s medium (Gibco) containing 5% newborn calf serum. 
About 5 X 106 cells were washed in ice-cold TBS (150 mM NaCl, 
40 mM Tris-HCl pH 7.4), sonicated in 200 mM NaCl, 40 mM Tris-HCl 
pH 7.4 containing 0.05% Nonidet P-40 as reported by Tyc and Steitz 
(1989) and centrifuged for 10 min at 10 000 g at 4°C. The supernatant 
was incubated with 2 mg of protein A-Sepharose beads swollen in the 
sonication buffer and saturated with anti-fibrillarin (72B9) or anti-hGARl 
antibodies, which were kindly provided by Drs J.A.Steitz and 
W.Filipowicz, respectively. After immunoprécipitation, the beads were 
washed four times with 10 vol of sonication buffer. Isolation of nuclei 
from HeLa cells, and fractionation of nuclei into nucleoplasmic and 
nucleolar fractions were performed as described (Tyc and Steitz, 1989).
Preparation o f probes for in situ hybridization
Synthesis and labelling of antisense RNA probes were performed 
according to the protocol of Dr R.Singer (http://singerlab.aecom.yu.edu). 
To produce probes specific for U85, U87, U89, U90, U92 and mgU6-53 
RNAs, fragments of these RNAs were amplified by PCR with 
oligonucleotides 17/18, 19/20, 21/22, 23/24, 25/26 and 27/28, respect­
ively. The 3'-end-specific primers carried the sequence of the T7 RNA 
polymerase promoter. The resulting DNA fragments were used as 
templates for in vitro transcription by T7 RNA polymerase in the 
presence of 5-(3-aminoallyl) uridine 5'-triphosphate. About 2-5 pg of 
RNA purified on a 6% sequencing gel was resuspended in 70 pi of 0.1 M 
Na-carbonate buffer pH 8.8 and mixed with 30 pi of dimethylsulfoxide 
containing a vial of FluoroLink Cy3-monofunctional dye (Amersham). 
Labelling was performed for 48 h in the dark, at room temperature, with 
occasional vortexing. The unreacted dye was removed by ethanol 
precipitation of the RNA. Specific activity of the probes was determined 
by absorption spectroscopy. To detect U88 and U91, amino-modified 
antisense oligonucleotides 29 and 30 were synthesized, respectively, and 
reacted with Cy3 monofunctional dye.
Fluorescent in situ hybridization and image acquisition and processing
HeLa cells were fixed in phosphate-buffered saline (PBS) buffer 
(100 mM Na2HP04, 20 mM KH2P04, 137 mM NaCl, 27 mM KC1 
pH 7.4) containing 4% formaldehyde for 30 min at room temperature. 
The cells were rinsed twice with PBS and permeabilized by incubation 
overnight in 70% ethanol. After rehydration in 2 X SSC (300 mM NaCl, 
30 mM sodium citrate pH 7.0) containing 50% formamide, cells were 
hybridized overnight at 37°C in 40 pi of a mixture containing 10% 
dextran sulfate, 2 mM vanadyl-ribonucleoside complex, 0.02% RNase- 
free bovine serum albumin (BSA), 40 pg of Escherichia coli tRNA, 2 X 
SSC, 50% formamide, 20 ng of labelled probe. Cells probed with 
fluorescent antisense RNA were washed twice for 30 min in 0.1 X SSC, 
50% formamide at 50°C, while oligonucleotide-treated cells were rinsed 
with 2 X SSC, 50% formamide, at 37°C. p80 coilin was detected with 
polyclonal rabbit anti-coilin antibody (1/100 dilution, kindly provided by 
Dr A.Lamond) followed by incubation with anti-rabbit antibodies 
conjugated to fluorescein (1/300 dilution, Sigma). Slides were incubated 
for 1 h at 37°C in PBS containing 1% BSA and washed twice for 15 min 
in PBS at room temperature. Slides were mounted in mounting media 
containing 90% glycerol, 1 X PBS, 0.1 pg/ml of 4',6-diamidino-2- 
phenylindole and 1 mg/ml p-phenylendiamine. Images were acquired on 
a DMRA microscope equipped for epifluorescence (Leica), and with a 
CoolS nap camera (Photometries) controlled by the software Metamorph 
(Universal Imaging). Images were then pseudo-coloured with Photoshop 
(Adobe Systems).
Accession numbers
The DDBJ/EMBL/GenBank accession numbers of human U87, U88, 
U89, U90, U91 and U93 scaRNAs are AY077737, AY77738, AY77739, 
AY77740, AY77741 and AY77742, respectively.
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Introduction
Several recently identified scaRNAs directing the 2’-0-ribose methylation and 
pseudouridylation of RNAPII-transcribed snRNAs were composed of a box C/D and box 
H/ACA snoRNA-like domains. During the sequence analysis of a cDNA library of human 
box H/ACA snRNAs, we have also identified a novel type of pseudouridylation guide RNA, 
the U93 RNA, that is composed of two tandemly arranged H/ACA snRNA domains and 
functions in pseudouridylation of the U2 spliceosomal snRNA. In situ hybridisation revealed 
a Cajal body-specific localization for U93, further supporting the idea that Cajal body 
provides the cellular locale for the post-transcriptional modification of spliceosomal snRNAs. 
By mutational analysis we demonstrated that all box elements of U93 snRNA are necessary 
for stable accumulation of the full length RNA. However, both the 5’- and the 3’-terminal box 
H/ACA RNA domains of U93 RNA could independently accumulate in the cell nucleus and 
posses functionally active localisation signals that can direct them into Cajal bodies.
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Abstract
^e -spec ific  post-transcriptional conversion of uri- 
dihes to pseudouridine in ribosomal RNAs and 
®nr|all nuclear RNAs (snRNAs) is directed by guide 
°NAs which possess the conserved box H and ACA 
®®quence elements and fo ld into the consensus 
Ja irp in -h inge -ha irp in -ta il’ secondary structure, 
i r®, we describe an unusual mammalian pseudour- 
'dyiation guide RNA, called U93, that is composed two tandem ly arranged box H/ACA RNA domains.
U93 RNA therefore carries two H and two ACA 
“ °x motifs, all of which are essential fo r accumula- 
tion of the fu ll-length RNA. The human U93 RNA 
^cumulates in Cajal (coiled) bodies and it is pre­y e d  to function in pseudouridylation o f the U2 
8Pliceosomal snRNA. Our results lend further sup- 
p0|t  to the notion that modification of the RNA poly- 
nie',ase ll-transcribed spliceosomal snRNAs takes 
plac® in Cajal bodies.
'^t r o d u c t io n
nucleus contains a large number of small nuclear RNAs 
^nRN^s) which possess diverse cellular functions (1). The 
Ul- U2, U4, U5 and U6 spliceosomal snRNAs play a pivotal 
in the removal of intron regions from pre-mRNAs. The 
r 7 snRNA directs 3'-end formation of histone mRN As and the 
^Nase P RNA functions in 5'-end processing of tRNAs. The 
U3> U8, U14, U22, snR30 and MRP small nucleolar RNAs 
^noRNAs) are required for the production of mature 
nbosomal RNAs (rRNAs) (2). Besides RNA processing, 
snRNAs also function in the regulation of transcription 
e‘°ngation by RNA polymerase (pol) II (7SK RNA) (3,4) 
in the synthesis of telomeric DNA repeats (telomerase 
^ A )  (5). All snRNAs associate with specific proteins and 
0rrn small nuclear or nucleolar ribonucleoprotein particles 
vsnRNPs or snoRNPs) (1).
The nucleus also contains an enormous number of modi­
fication guide RNAs which direct the post-transcriptional 
synthesis of 2'-0-methylated nucleotides and pseudouridines 
in rRNAs, spliceosomal snRNAs and, most likely, other 
cellular RNAs (for recent reviews, see 6-11). The 2'-O - 
methylation guide RNAs possess the conserved box C 
(RUGAUGA) and D (CUGA) elements that are frequently 
tethered by a short 5',3'-terminal stem (Fig. 1). The internal 
region of box C/D RNAs carries the C  and D' boxes which 
represent perfect or imperfect copies of the C and D boxes 
(12,13). The pseudouridylation guide RNAs are characterised 
by a consensus ‘hairpin-hinge-hairpin-tail’ structure and they 
carry the conserved H (ANANNA) and ACA box elements 
(14,15). The H box is located in the single-stranded hinge 
region after the 5' hairpin. The ACA box is found in the 
3'-terminal tail 3 nt before the end of the RNA. The box C/D 
2'-(9-methylation guide RNAs are associated with four 
RNP proteins, fibrillarin/Noplp, Nop56p, Nop58p and 
15.5kD/Snul3p, whereas the box H/ACA pseudouridylation 
guide RNAs specifically bind dyskerin/Cbf5p, Garlp, Nhp2p 
and NoplOp (reviewed in 8-10). The guide RNAs provide 
scaffolding for the associated RNP proteins and select the 
target nucleotide by forming direct base-pairing interactions 
with the substrate RNA. In turn, the RNP proteins provide 
metabolic stability for the guide RNAs and catalyse the 
modification reactions. Most likely, the fibrillarin/Noplp and 
dyskerin/Cbf5p RNP proteins perform the 2'-0-methyl trans­
fer and the uridine to pseudouridine isomerisation reactions, 
respectively (16,17).
The modification guide RNAs accumulate either in the 
nucleolus or in the Cajal body and, accordingly, they are 
called snoRNAs or small Cajal body-specific RNAs 
(scaRNAs) (2,18). The two groups of modification guide 
RNAs possess different functions. The snoRNAs direct 2'-0- 
methylation and pseudouridylation of rRNAs (19-23) and 
the RNA pol Ill-transcribed U6 spliceosomal snRNA 
(24-26). The scaRNAs function in modification of the RNA 
pol II-specific U l, U2, U4 and U5 spliceosomal snRNAs 
(18,27).
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cBox C/D
Figure 1. Classification of 2'-0-methylation and pseudouridylation guide 
RNAs. Schematic representation of the consensus two-dimensional 
structures of box C/D 2'-0-methylation, box H/ACA pseudouridylation and 
box C/D-H/ACA composite 2'-0-methylation and pseudouridylation guide 
RNAs. Positions of the conserved box elements are indicated.
The scaRNAs are frequently composed of a box C/D and a 
box H/ACA RNA-like domain (Fig. 1) and they can function 
both in 2'-0-methylation and pseudouridylation of snRNAs 
(18,27). Here, we describe a novel mammalian scaRNA, 
called the U93 RNA, that is predicted to function in 
pseudouridylation of the RNA pol II-specific U2 spliceosomal 
snRNA. Surprisingly, the human, mouse and cow U93 
scaRNAs are composed of two tandemly repeated box 
H/ACA domains and therefore they contain two H and two 
ACA boxes which are all essential for accumulation of the 
full-length U93 RNA.
MATERIALS AND METHODS
G eneral procedures
Unless stated otherwise, all techniques for manipulating DNA, 
RNA and oligonucleotides have been done as described by 
Sambrook e t al. (28). The following oligonucleotides were 
used in this study: 1, ATGCCTCAGCTTCCTCT; 2, CAG- 
ACTTGCAGAAAAAGCA; 3, CAGTACTTAGTGTTCAA- 
CAGA; 4, AT A ATCG AT A ATCTGT AGTCTTGG AGCCGC ; 
5, ATAGTCGACACTTGTGGCAGTACTTAGTG; 6, CAG- 
CTTCCTCTGGAGTAGGGGGGTTCTGCAAGTCTGGTG- 
T; 7, CAACAGTGACCAGAAACGGGCAGAGGAAAATT- 
GCACA; 8, TCTATCCGCCAACAGTACCCCCCGCTTT- 
GC AGTCGAGAT A; 9, T AT AGTCG AC ACTGGGGGC AG- 
TACTTAGTGTTC; 10, GTG AT A ATG ACTGGGCT AT- 
GTC; 11, A AT ACG ACTC ACT AT AGGGGGC AGT ACT - 
TAGTGTTCAACAG; 12, AT*CTCG AGGGT ACCACCAA- 
T*CCTGTGCGGCTCCAT*A (amino-allyl-modified T resi­
dues are marked by asterisks).
Characterisation o f hum an, mouse and cow U 93 RNA*
A recombinant plasmid carrying a full-length cDNA d' 
human U93 scaRNA was identified during characterisatio1' 
a cDNA library of human HeLa snRNAs. Synthesis* 
cloning of cDNAs has been described (19). The 5' termin'1: 
U93 was confirmed by primer extension analysis usings 
terminally labelled oligonucleotide 1 as a primer. 
cDNAs of the mouse and cow U93 scaRNAs were obtain^  
RT-PCR using oligonucleotides 2 and 3 as primers. The P^ 
amplified fragments were cloned into the S m a l site1 
pBluescript (Stratagene) and subjected to sequence anal': 
The 3'-terminal sequences of the mouse and cow U93 RjL 
were determined by the oligoribonucleotide ligation-___ ______  ptf
amplification procedure (29), except that oligonucleoti^  
was used as a U93-specific upstream primer. The 5,-tem'":; 
sequences of mouse and cow U93 RNAs were déterminé 
the RNA 5'-RACE procedure using oligonucleotide 1 * 
primer.
Expression constructs
The coding region of the human U93 RNA gene was 
amplified by using oligonucleotides 4 and 5 as primers 
human genomic DNA as a template. The PCR product . 
digested with C la l and S a il and inserted into the C la l and A 
sites of the pCMV-globin expression vector (18), resulti"| 
pCMV-globin-U93. Construction of derivatives of p^o 
globin-U93 carrying U93 genes with altered HI, H2 jj 
ACA1 boxes was performed by the megaprimer amplifiai 
approach using pCMV-globin-H93 as a template (30)- 1 
obtain pCMV-globin-U93//7 and pCMV-globin-U93/R^  
the 5' half of the U93 gene was amplified with oligon"c' 
otides 6 and 7 as mutagenic 3 ' primers, respectively.^  
oligonucleotide 4 as a 5'-end-specific primer. The y 
products were used as megaprimers in the second ampl* 
tion step in combination with a common 3'-end-speClf 
primer (oligonucleotide 5). The amplified products  ^
digested with C la l and M lu l and cloned into the C la l and P  
sites of pCMV-globin. A similar strategy was used to gen^ J 
pCMV-globin-U93//2, except that a megaprimer was ge^  
ated with oligonucleotides 5 and 8 as 3'- and 5'-end-speCl, 
primers, respectively. In the second step of amplified 
oligonucleotide 4 was used as a 5'-end-specific 
Finally, amplification of the human U93 RNA gene  ^
oligonucleotides 4 and 9 resulted in U93AG42, which 
inserted into the C la l and X h o l sites of pCMV-globin, yield? 
pCMV-globin-U93A C A 2. The identity of each express' 
construct was verified by sequence analyses. Constructio" ! 
the coilin-Dsred2 expression vector has been described vl 
Transfection of simian COS-7, human HeLa and mouse 1$' 
cells has been described (18).
Im m unoprécip itation, cell fractionation and R N A  
analysis
Immunoprécipitation of human snRNPs with anti-fibrill^  
and anti-hGARl antibodies (kindly provided by Drs J- 
Steitz and W. Filipowicz, respectively) was performed 
described (18). Fractionation of HeLa cells into nudeJ 
nucleoplasmic, nucleolar and cytoplasmic fractions 
performed according to Tyc and Steitz (32). From CO*  
and HeLa cells and the nuclear, nucleolar, nucleoplasmic ^
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ytoplasmic fractions of HeLa cells, RNA was isolated by the 
banidine thiocyanate/phenol-chloroform extraction proced- 
re (33). RNase A/Tl protection was performed as described 
y Goodall e t  a l. (33). For mapping of U93, U93//7, 
'3AC47, U93H 2  and U93ACA2 RNAs, sequence-specific 
. A Probes were synthesised by SP6 RNA pol using N d e l-  
Jgested pCMV-globin-U93, pCMV-globin-U93W, pCMV- 
obin-U93ACA/, pCMV-globin-U93//2 and pCMV-globin- 
3ACA2 plasmids as templates. Probes for U3, U4 and U19 
1RNAs have been described (18). After synthesis, all probes 
ere purified on a 6 %  sequencing gel.
n si*u hybridisation
Plu***** in  s itu  hybridisation, image acquisition and 
^  ess'ng has been described (18). To generate antisense 
gen Pr°be for the human U93 RNA, a fragment of the U93 
"'ith r^°m P05'1’00 159 to position 269 was PCR-amplified 
0|j °ligonucleotides 10 and 11 as primers. Utilisation of 
incf0nuc'e°tide 11 as a 3'-end-specific primer resulted in 
am *|S'°n RNA polymerase promoter into the
(P'fied fragment. The resulting PCR product was used as a 
tjle P'ate for in  v itro  transcription by T7 RNA polymerase in 
P^ sence of 5-(3-aminoallyl) uridine 5'-triphosphate. 
R ecti°n of the 5'-terminal box HI A C A  domain of the U93 
A was performed by using an oligonucleotide probe 
(o^ Plementary to the human U93 RNA from position 13 to 44 
ProK°nUC*eot'cle 12). The modified RNA and oligonucleotide 
dy es were labelled with FluoroLink™ Cy5-monofunctional 
j^ r^ . mersbam) according to the protocol of the laboratory of 
bas h^Cr (bfrp^ /singerlab.aecom.yu.edu). Human p80 coilin 
(ki °Cen e^tecte(l by polyclonal rabbit anti-coilin antibody 
provided by Dr A. Lamond) as it has been described
RESULTS
Identification of a novel Garlp-associated human box 
H /A C A  R N A
During sequence analysis of a cDNA library of human HeLa 
snRNAs, we have identified a 275 nt long RNA that showed 
no significant sequence similarity to any known human RNA 
(Fig. 2). Northern analysis and RNase A/Tl protection 
experiments confirmed that the new RNA, called hereafter 
as U93, efficiently accumulates in HeLa cells (Figs 3 and 4; 
data not shown). The presence of an ACA triplet 3 nt before 
the 3' terminus of the U93 RNA indicated that it might belong 
to the family of box H/ACA RNAs. Indeed, a monoclonal 
antibody directed against the human Garl protein, a 
component of box H/ACA RNPs, specifically precipitated 
the U93 RNA as well as the U19 box H/ACA snoRNA from a 
human HeLa cell extract (Fig. 3A). In contrast, an anti- 
fibrillarin antibody failed to precipitate both U93 and U19, but 
recognised the fibrillarin-associated U3 box C/D snoRNA. As 
expected, neither the anti-fibrillarin nor the anti-GARl 
antibody reacted with the U4 spliceosomal snRNP, demon­
strating that the human U93 RNA specifically associates with 
the Garl snoRNP protein and it belongs to die family of box 
H/ACA RNAs.
M a m m a lia n  U 93 snR N A  Is composed o f two box H /A C A  
R N A -lik e  domains
Computer modelling was used to generate a secondary 
structure for the human U93 RNA (34). In contrast to the 
consensus ‘hairpin-hinge-hairpin-taiT structure of box 
H/ACA snoRNAs (Fig. 1), the computer-predicted structure 
of U93 is composed of four hairpins connected by three single- 
stranded hinge regions and terminated by a short tail (Fig. 2).
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Figure 3. Characterisation of human U93 RNA. (A) Immunological charac­
terisation of U93 RNP. RNAs recovered from the pellet of immunoprécipi­
tation reactions performed with anti-hGARl (a-Gar), anti-fibrillarin (a-Fib) 
or a control non-immune serum (Nonim) from a human HeLa cell extract 
were mapped with sequence-specific antisense RNA probes indicated on the 
right. Lanes C and E show control mappings with RNAs obtained from 
Escherichia coli and HeLa cell extracts, respectively. Lane M, size marker 
(a mixture of HeaWl- and Tmjl-digested pBR322). (B) Cell fractionation. 
RNA isolated from HeLa cells (T), from the nuclear (Nu), nucleoplasmic 
(Np), nucleolar (No) and cytoplasmic (Cy) fractions of HeLa cells were 
mapped by sequence-specific antisense RNA probes as indicated on the 
right. (C) In situ localisation of U93 RNA. Human HeLa cells either trans­
fected (bottom) or non-transfected (top) with the pCMV-globin-U93 expres­
sion construct (see Fig. 4A) were probed with a fluorescent RNA probe 
complementary to the human U93 RNA. Cajal bodies were detected by an 
antibody directed against human p80 coilin. Merged images show that the 
U93 RNA co-localises with p80 coilin both in transfected and non-trans­
fected cells. The nuclei of non-transfected cells are highlighted by dotted 
lines. Under the exposure conditions shown, the endogenous U93 RNA 
remains invisible in non-transfected cells. (D) Potential base-pairing inter­
action of the human U93 and U2 RNAs. The 3'-terminal hairpin of U93 is 
schematically indicated. The U54 residue known to be pseudouridylated in 
vertebrate U2 snRNAs is indicated O P ) .
We noticed that the first and third hairpins of U93 are followed 
by potential box H sequences (63-AAAGCA-68 and 202- 
AGAGAA-207) and that the second and the last hairpins are 
followed by potential box ACA motifs (134-AUA-136 and 
270-ACA-272). This strongly suggested that the human U93 
RNA is composed of two tandemly arranged box H/ACA 
RNA domains.
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Figure 4. Transient expression of human U93 RNA in COS-7 
(A) Schematic representation of the pCMV-globin expression construe1 
CMV promoter, full-length (El and E2) and partial (E3) exons of the Wjj, 
(3-globin gene, the SP6 RNA polymerase promoter (SP6) and the Pj 
adenylation region of the bovine growth hormone gene (PA) are indie®. 
Relevant restriction sites are shown (N, NdeV, H, Hindlll; C, Clal; ® 
Xhol). Open arrow indicates the coding region of human U93 RNA-1”. 
U93-HI, U93-ACA1, U93-/Y2 and U93-ACA2 constructs, the indicated^ 
element was replaced for a stretch of C residues. (B) RNase A ATI pro16®
mapping reactions with RNAs obtained from non-transfected and transi 
cells, respectively. Lane H, mapping of HeLa cellular RNAs. RNA
are indicated on the right. Lane M, size marker in nucleotides.
Northern analysis of mouse, rat, cow and carp nuc>®.
RNAs performed with a human U93-specific antisense
l l :probe revealed hybridising RNAs of the size of human 
(data not shown). The full-length sequences of the mouse r  
cow U93 RNAs were obtained by RT-PCR followed by , 
and 3'-end RACE experiments (see Materials and Methods)’ 
comparison of the sequences and two-dimensional struck. 
of the human, mouse and cow U93 RNAs is shown in Fignfe' 
Strikingly, most of the evolutionarily variable nucleotides 
located in predicted single-stranded regions, namely in “ 
three hinge and the 3'-terminal tail regions as well aS, 
internal and terminal loop structures. Contrary to the fact1? 
the hinge regions show the highest sequence v a ria b il1
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nudeotides in the putative HI, H2, ACA1 and ACA2 motifs 
R\ per e^ctly conserved in the human, mouse and cow U93 
pointing to the functional importance of these 
f e n c e s .  In most cases, altered nucleotides located in 
°uble-stranded regions do not interfere with the formation of 
^dect double helices (see positions U7, A107, A164, A 165, 
* l96. G184, G232, A254). Even more tellingly, transition of 
e A168 residue to a G residue in the cow U93 RNA is 
^stored by a U to C compensatory base change in the opposite 
s|tand of the proposed double helix. Taken together, these 
°bservations strongly supported the correctness of the 
Proposed secondary structure of U93 and confirmed the 
^"elusion that the mammalian U93 RNA is composed of two 
x H/ACA snoRNA-like domains.
Jbe human U93 RNA specifically accumulates in Cajal 
bodies
Mammalian box H/ACA RNAs accumulate either in the 
"Ucleolus or in the nucleoplasmic Cajal bodies (8,18). Upon 
^donation of human HeLa cells, the U93 RNA and the U4 
spbceosomal snRNA were found mainly in the nucleoplasmic 
Action, while the U19 box H/ACA and the U3 box C/D 
Identic snoRNAs co-purified with the nucleolar fraction 
*¡'8- 3B). To determine the precise nucleoplasmic localisation 
?  U93, we used in situ  fluorescent microscopy (Fig. 3C). 
Robing of HeLa cells with a U93-specific fluorescent 
aafisense RNA probe revealed that the U93 RNA localises 
0 sharp dot-like structures in the nucleoplasm. Staining e 
cells with an antibody directed against p80 coilin, a 
{Molecular marker of Cajal bodies (35), demonstrated that the 
U93 RNA perfectly co-localises with p80 coilin. Likewise, 
transient overexpression of the human U93 RNA m 
{"■La cells (for details, see below), the overproduced U93 
{/^A showed a specific co-localisation with p80 coilin. Thus 
all box C/D and box H/ACA RNAs residing in Cajal 
T^'es have been implicated in post-transcriptional modifica- 
Or»ofpol II-specific spliceosomal snRNAs (8,11,18). In ee , 
noticed that sequences in the internal loop ° f  " 
^ n a l  hairpin of U93 are capable of positioning the U54 
residue in the U2 snRNA for pseudouridylation (Fig. 3D). We 
£0r>cluded that (i) the U93 box H/ACA-H/ACA composite 
^A represents a new member of scaRNAs and (ii) the 
^aRNA likely functions in pseudouridylation of the RNA pol 
' sPecific U2 spliceosomal snRNA.
laments essential for accumulation of the U93 box 
^ACA-H/ACA scaRNA
^  box H and ACA elements play a crucial role in 
Cumulation of yeast and mammalian box H/ACA 
CRNAs (14,15). Since the U93 RNA possesses two putative 
S  H (HI and H2) and ACA (ACA1 and ACA2) elements, we 
7 Ve tested the functional importance of each of these 
C lients in RNA accumulation. The genomic copy of the 
human U93 RNA is located in an intron of a series of reported 
?Pliced expressed sequence tags, indicating that the U93 RN 
,s generated by intron processing (36,37). Therefore, to 
exPress the human U93 RNA, its coding region was inserted 
'nto the second intron of the human P-globin gene controlled 
y the cytomegalovirus (CMV) promoter (Fig. 4A). The 
Suiting pCMV-globin-U93 expression construct was trans­
i t e d  into simian COS-7 cells and expression of the U93
RNA was tested by RNase A/Tl mapping using a sequence- 
specific antisense RNA probe (Fig. 4B, lane 3). As compared 
with the authentic human U93 RNA (lane 1), the plasmid-bom 
U93 RNA was faithfully processed from the globin 
pre-mRNA, further supporting the notion that U93 is indeed 
an intron-encoded RNA.
When either the box HI, ACA1, H2 or ACA2 motif of the 
U93 gene was replaced with a C stretch of appropriate length 
in the pCMV-globin-U93 construct, accumulation of the full- 
length U93 RNA was completely abolished in transfected 
COS-7 cells, although the globin host mRNA was correctly 
expressed in each case (Fig. 4B, lanes 5, 7, 9 and 11). Upon 
disruption of the box HI or ACA1 motif, RNase mapping 
resulted in accumulation of a protected RNA doublet with a 
molecular size that corresponds to the predicted length of the 
processed 3'-terminal box H/ACA domain of the U93 RNA 
(-130 nt) (Fig. 4B, lanes 5 and 7). On the other hand, alteration 
of the H2 or ACA2 motif resulted in the accumulation of an 
RNA of the expected size (-140 nt) of the 5'-terminal H/ACA 
domain of U93 (Fig. 4B, lanes 9 and 11). Indeed, the identity 
of these RNAs was confirmed by RNase mappings performed 
with probes specific for either the 5'- or the 3'-terminal half of 
the U93 RNA (data not shown). These results demonstrated 
that both the 5'- and the 3'-terminal box H/ACA RNA domains 
of the human U93 RNA can independently accumulate. 
However, mapping of HeLa cellular RNA failed to detect any 
accumulating fragment of the U93 RNA (Fig. 4B, lane 1, and 
data not shown), indicating that normally neither the 5'- nor 
the 3'-terminal box H/ACA domain of U93 is expressed 
separately.
We next investigated whether the 5'- and 3'-terminal 
domains of the U93 RNA, when they are expressed inde­
pendently, still accumulate in Cajal bodies. Mouse cells 
transfected with the pCMV-globin expression construct 
carrying the U93, V 93-H 1  or U93-H 2  genes were probed 
with fluorescent antisense probes specific for the 5'- and 3'- 
terminal domains of the U93 RNA (Fig. 5). The Cajal bodies 
of the transfected mouse cells were visualised by co-expres­
sion of the coilin-Dsred2 fluorescent recombinant protein. 
Similar to the full-length human U93 RNA, both the 5'- and 3'- 
terminal box H/ACA domains of the RNA accumulated in 
Cajal bodies. This demonstrates that both box H/ACA 
domains of U93 possess functionally active localisation 
signals which can direct the Cajal body-specific accumulation 
of the two domains independently of one another.
DISCUSSION
Site-specific synthesis of 2'-0-methylated nucleotides and 
pseudouridines in rRNAs and spliceosomal snRNAs is 
directed by guide RNAs which can be classified into 
three structurally and functionally well defined families 
(Fig. 1). The box C/D RNAs direct 2'-0-methylation 
and the box H/ACA RNAs guide pseudouridylation of 
rRNAs and snRNAs. Another minor group of composite box 
C/D-H/ACA RNAs function both in 2'-0-methylation and 
pseudouridylation of snRNAs (18,27). In this study, we have 
identified and characterised a novel type of pseudouridylation 
guide RNA. The U93 RNA is composed of two tandemly 
arranged box H/ACA RNA domains and, therefore, it carries 
two box H and ACA motifs. This unique architecture of the
5' p r o b e  c o ilin  men
U93
U93-H2
U93
U93-Hf
Figure 5. In situ localisation of the 5'- and 3'-terminal box H/ACA domains 
of human U93 expressed in mouse cells. Mouse L929 cells were transfected 
with the pCMV-globin-U93, pCMV-globin-U93//7 and pCMV-globin- 
U93H2 expression constructs (see Fig. 4A). The transiently expressed U93 
RNA was visualised by a fluorescent oligonucleotide or an antisense RNA 
probe specific for the 5'- and 3'-terminal domain of the human U93 RNA, 
respectively. Cajal bodies of mouse cells were detected by co-expression of 
the coilin-Dsred2 fluorescent protein. For other details, see the legend to 
Figure 3C.
U93 RNA is conserved at least in human, mouse and cow 
(Fig. 2).
Previous characterisation of the human U85 box C/D-H/ 
ACA composite RNA showed that the unusual structural 
organisation of this class of modification guide RNAs could be 
explained by several facts. Alteration of the 5'-terminal C or 
the 3'-terminal D box of the U85 RNA completely abolished 
the expression of both the full-length U85 RNA and box 
H/ACA domain of the RNA (27). This indicated that 
accumulation of the human U85 box C/D-H/ACA RNA is 
supported exclusively by its box C/D domain and that the box 
H/ACA domain of the RNA lacks metabolic stability. In the 
case of the newly discovered U93 box H/ACA-H/ACA 
composite RNA, all conserved box elements (HI, ACA1, 
H2 and ACA2) are required for accumulation of the full- 
length RNA. However, accumulation of the 5'- and 3'-terminal 
box H/ACA domains of U93 is not interdependent. In other 
words, both box H/ACA domains of the U93 RNA possess all 
those elements which are essential for accumulation (Fig. 4).
Thus far, all 2'-0-methylation and pseudouridylation guide 
RNAs implicated in modification of the RNA pol II-specific 
U l, U2, U4 and U5 spliceosomal snRNAs have been found to 
reside in the nucleoplasmic Cajal bodies (18). It seems that 
these guide RNAs possess specific m-acting targeting elem­
ents which are responsible for the their Cajal body specific 
localisation. Currently, we have found that the Cajal
body-specific localisation signals of the human U85 
ACA scaRNA are located in the box H/ACA domain of 
RNA and that the box C/D domain of U85 alone ca®* 
localise to Cajal bodies (P.Richard, X.Darzacq, C .V e rh e g r  
E.Bertrand and T.Kiss, manuscript in preparation). The huj1” 
U93 box H/ACA-H/ACA RNA also accumulates in ^  
bodies and, unexpectedly, both box H/ACA domains of 
U93 RNA possess functionally active Cajal body-sp^'
targeting elements (Fig. 5). So, in contrast to the U85 box 
H/ACA RNA, the unusual structural organisation of the 
box H/ACA-H/ACA RNA cannot be explained by 15 
metabolic instability or incorrect intracellular trafficking1 
the two domains of the RNA.
The box C/D and H/ACA domains of the U85 ^  
function in 2'-0-methylation and pseudouridylation of 
neighbouring nucleotides in the U5 spliceosomal snRNA-J? 
suggests that co-expression of guide RNAs directing ®°(' 
cation of the same substrate RNA is advantageous for the1* 
(27). The putative pseudouridylation pocket in the 
hairpin of the U93 RNA is predicted to direct pseudouriw. 
tion of the U2 spliceosomal snRNA at position U54 (Fig- ^  
Since both the 5'- and 3'-terminal hairpins of box H/^ 
RNAs can carry functional pseudouridylation pockets (23’, 
the four hairpins of the U93 box H/ACA-H/ACA RNA; 
principle, could direct pseudouridylation of four diffo* 
substrate uridines. It seems, however, unlikely that the “ 
and third hairpins of U93 contain functional pseudouridyl^ 
pockets, since several evolutionarily altered nucleotide5 
present in these regions (Fig. 2). On the contrary, the se^ 
hairpin carries a conserved internal loop that possesses 
characteristic topology of a functional pseudouridyl2? 
pocket. This putative pseudouridylation pocket of 
lacks complementarity to rRNAs, spliceosomal snRNA5' 
any known stable RNAs, including tRNAs. Therefor6' . 
seems likely that the second hairpin of the U93 ^  
directs pseudouridylation of a not yet identified 
Whether this putative target RNA of U83, like all subsdj 
RNAs of Cajal body-specific guide RNAs, has a cell2' 
function related to pre-mRNA splicing remains an intrig1^  
speculation. -
In summary, identification of the U93 RNA tha* 
composed of two box H/ACA RNA domains further supr 
the idea that snRNA structural domains are frequently use2' 
build novel composite RNAs. In addition to the r e c ^  
characterised box C/D-H/ACA scaRNAs (18,27), the v«2 
brate and yeast telomerase RNAs carry a box H/ACA and* 
domain, respectively (39,40). In principle, acquisition 01! 
structurally and functionally well defined snRNA domain h’jj 
contribute to metabolic stability, may direct intracell1! 
trafficking or may provide a new cellular function fof 
newly made composite RNA.
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Introduction
Pseudouridine, the most abundant modified nucleoside in stable cellular RNAs is 
synthesised by posttranscriptional isomerisation of uridines. In eukaryotic RNAs, site-specific 
synthesis of pseudouridines is directed primarily by box H/ACA guide RNAs. Moreover, box 
H/ACA RNA domains are present in several important cellular RNAs that apparently do not 
function in pseudouridylation. Since only a limited number of box H/ACA RNAs were known 
in humans, it remained unclear to what extent box H/ACA domain containing RNAs 
participate in different cellular processes. By systematic search for novel box H/ACA 
snRNAs we identified 61 previously unknown RNAs. As expected most of the newly 
identified box H/ACAs are predicted to direct pseudouridylation of ribosomal RNAs and 
spliceosomal snRNAs. The human 18S, 5.8S and 28S rRNA contain almost 100 
pseudouridines. Currently, we can link guide RNAs to more then 80% of the known 
ribosomal and spliceosomal pseudouridylation sites. We also identified the first human guide 
RNA predicted to guide pseudouridylation of the RNAPIII-specific U6 spliceosomal RNA 
and several scaRNAs, involved in pseudouridylation of RNAPII-specific snRNAs. More 
importantly, we have identified 12 novel box H/ACA snRNAs of unknown function. Also the 
genomic organization of box H/ACA snRNAs has been analysed. I also identified two novel 
28S rRNA méthylation guide box C/D snoRNAs, which were genetically linked to box 
H/ACA snoRNAs.
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. posttranscriptional covalent modification of ribonucleotides 
!s an important step in the biosynthesis of stable cellular RNAs, 
"’eluding tRNAs, rRNAs, small nuclear RNAs (snRNAs), and 
?mall nucleolar RNAs (snoRNAs) (40). Biochemical, biophys- 
lcal> and genetic studies have shown that modified nucleotides 
are important for the appropriate function of mature RNAs; 
,hey facilitate correct RNA folding and contribute to the for- 
mation of appropriate RNA-RNA and RNA-protein mterac- 
,lons (reviewed in references 1, 7, 12, 15, and 44).
While in tRNAs, most modified nucleotides are synthesized 
“7 protein enzymes, in eukaryotic rRNAs and snRNAs, site- 
5pecific synthesis of the most prevalent modified ribonucleotides, 
*l)e 2’-0-ribose-methylated nucleotides and the pseudoun- 
'Unes, is achieved by two distinct families of ribonucleoprotems 
(RNPs) (reviewed in references 14, 18, 27, 28, and 52). The 
"’odification guide RNPs consist of a sequence-specific guide 
^NA and a set of common proteins. Each 2 -O-ribose met 
Ration guide RNA carries the conserved C, C' (consensus, 
^UGAUGA), D, and D' (CUGA) box motifs and possesses 
°ne or two 10- to 2 1-nucleotide-long antisense elements that 
are responsible for selection of the correct substrate nbonucle- 
ofctes through the formation of double helices with the target 
**NAs (11, 32). The selected ribonucleotides are 2'-0-nbose 
methylated by the Noplp/fibrillarin methyltransferase enzyme 
5**at, in addition to the Snul3 (15.5-kDa), Nop56p, an 
N°P58p RNP proteins, is associated with all box C/D RNAs
(l4> 18, 27, 52, 55). . ,
The pseudouridylation guide RNAs are composed o two
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major hairpin elements that are connected by a hinge and 
followed by a short tail region (Fig. 1A). The single-stranded 
hinge and tail region carry the conserved H (consensus, ANA 
NNA) and ACA box motifs that are located at the bases of the 
5' and 3' hairpins, respectively (6, 20). Two short antisense 
elements located in an internal loop of the 5' and/or 3' hairpins 
provide the sequence specificity for the pseudouridylation 
guide RNP by base pairing to the sequences that precede and 
follow the target uridine. This interaction creates the 
“pseudouridylation pocket,” in which the unpaired substrate 
uridine selected for pseudouridylation is located 14 or 15 bp 
upstream of the H or ACA motif of the guide RNA (19, 43). 
TTie dyskerin/Cbf5p pseudouridine synthase, together with the 
Nhp2, NoplO, and Garl RNP proteins, is an integral compo­
nent of box H/ACA pseudouridylation guide RNPs (33, 56).
Vertebrate box H/ACA pseudouridylation guide RNAs are 
processed from removed and debranched pre-mRNA introns 
by exonucleolytic activities (18). The conserved H and ACA 
boxes together with the basal helices of the 5' and 3' hairpins 
provide the signals for correct RNA processing (6, 8, 20). The 
mature H/ACA RNAs accumulate either in the nucleolus 
(snoRNAs) or in nucleoplasmic Cajal bodies (small Cajal 
body-specific RNAs [scaRNAs]). The nucleolar accumulation 
of box H/ACA snoRNAs is supported by the conserved H and 
ACA boxes and the basal helix of the 3' hairpin (34, 42). The 
box H/ACA scaRNAs carry a common Cajal body-specific 
localization signal, the CAB box (consensus, UGAG), that is 
found in the terminal loops of the 5' and 3' hairpins (47). In 
the nucleolus, most box H/ACA snoRNAs direct pseudouridy­
lation of the 18S, 5.8S, and 28S rRNAs (19, 43), while the box 
H/ACA scaRNAs function in pseudouridylation of the RNA 
polymerase II (pol II)-transcribed spliceosomal snRNAs (13, 
25, 26).
In the yeast Saccharomyces cerevisiae, most, if not all, ribo- 
somal pseudouridines are synthesized by box H/ACA snoRNPs
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FIG. 1. Schematic structure of box H/ACA RNAs and cDNA con­
struction. (A) Selection of pseudouridylation sites by box H/ACA 
guide RNAs. For details, see the text. (B) Construction of a cDNA 
library of human box H/ACA RNAs. HeLa cell RNAs immunopre- 
cipitated by an anti-GARl antibody were incubated with a phosphor- 
ylated oligoribonucleotide in the presence of T4 RNA ligase. RNA 
sequences tagged at both termini were converted into double-stranded 
DNA by a reverse transcription-PCR amplification approach. The 
amplified DNA was cloned into a plasmid vector, and individual clones 
were characterized by sequence analysis.
(49). Since only a limited number of box H/ACA RNAs have 
been identified in humans, it remains unknown to what extent 
guide RNAs participate in the pseudouridylation of human 
cellular RNAs (13, 20, 25, 26, 29, 31, 48, 54). A recent identi­
fication of partial sequences of several putative box H/ACA
snoRNAs in mice suggested that mammalian cells express a 
large number of box H/ACA RNAs (23). In this study, 
identification of 61 novel human box H/ACA RNAs provided 
us with new insights into the function and organization of the 
molecular machinery directing the pseudouridylation of hu­
man rRNAs, snRNAs, and probably other cellular RNAs.
MATERIALS AND METHODS
Construction and characterization of a cDNA library of human box H/ACA 
RNAs. Preparation of HeLa cell extracts and immunoprécipitation by a GAP 
antibody of box H/ACA RNPs were performed essentially as described pteVI" 
ously (20), except that HeLa cells were sonicated in 40 mM Tris-HCl (pH 7.5) 
buffer containing 200 mM NaCl and 0.05% Nonidet P-40. The anti-huntai1 
GAR1 (hGARl) antipeptide antibody was kindly provided by W. Filipowicz 
(Friedrich Miescher Institut, Basel, Switzerland). About 0.3 pg of RNA rectW" 
ered by immunoprécipitation with the anti-hGARl antibody was mixed with 40 
pmol of 5'-end-phosphorylated oligoribonucleotide (pAAUAAAGCGGCCGC 
GGAUCCAA) and incubated with 15 U of T4 RNA ligase (Promega) and 10 0 
of RNase inhibitor (Promega) as described previously (17). After phenol-chlo­
roform extraction, the ligation products were recovered by ethanol précipitai*0^  
annealed with 40 pmol of oligodeoxynucleotide PI (TTGGATCCGCGGCCGC 
T H  AT), and used as a template for cDNA synthesis with avian myeloblastosis 
virus reverse transcriptase (Promega). The resulting first-strand cDNA was use" 
as a template for PCR amplification by Vent polymerase (Promega) with o'1 
godeoxynucleotides PI and P2 (AATAAAGCGGCCGCGGATCCAAA) 33 
primers. The amplified DNA was digested with BamHI, inserted Into the BatnH 
site of pBluescribe (Stratagene), and transformed into Escherichia coli DH5<* 
cells. Plasmid purification and sequence analysis were performed according 10 
standard laboratory protocols (50).
Mapping of pseudouridines. Isolation of RNA from human HeLa cells was 
performed by the guanidine thiocyanate-phenol-chloroform extraction proce­
dure (21). Detection of pseudouridines in the 18S and 28S rRNAs was per­
formed by primer extension analysis of carboxymethy! cellulose (CMC)-alka11" 
treated HeLa cell RNAs (5). 32P-labeled oligonucleotides complementary to the 
human 18S rRNA from positions C238 to U256 (Ÿ222), U685 to G700 (4*f>13 
and 9*655), C762 to U784 (9*690), and A1374 to C1393 (9*1330 and 9*1351) were 
used as primers. Mapping of 9*2496 In the 28S rRNA was performed with a 
primer complementary to the 28S rRNA from positions A2531 to C2548. F°r 
numbering of human 18S and 28S rRNAs, see GenBank accession number 
U13369. The primer extension products were fractionated on 6% sequencing 
gels.
Expression constructs. The ACA26, ACA35, and ACA57 scaRNAs were 
overexpressed in human HeLa cells. To this end, the coding regions of ACA# 
(oligonucleotides ACTAATCGATTACATTTTGAAGTrAGTGG and TCTA 
ACGCGTTTGAAATAAGTCAATAAG), ACA35 (oligonucleotides ACT-AA3 
CGATTAGACCTGAGATGTGCTTA and TCTAACGCGTACAGTCACTAA 
AGCCGTA), and ACA57 (oligonucleotides ACTAATCGATGTAAGTCrGC 
CTGTCCTAT and TCTAACGCGTCTTAGGACGGCCCTCCTA) were PCR 
amplified with HeLa cell genomic DNA as a template. The amplified fragmenIS 
were digested with restriction endonucleases Clal and Xhol and inserted into tW 
same sites of the pCMV-globin expression construct (13). Transfection of HeL3 
cells was performed with Fugene 6 (Roche) transfection reagent according to the 
manufacturer’s instructions.
Fluorescence in situ hybridization. Synthesis and chemical conjugation A 
amino-modified oligodeoxynucleotides with FluoroLink Cy3 monofunctional dye 
(Amersham), fluorescence hybridization of transfected HeLa cells, and image 
acquisition and processing were performed as described elsewhere (httpy/singerhh 
.aecom.yu.edu) (13). The following oligonucleotide probes were used to detect 
transiently expressed human scaRNAs (asterisks indicate amino-allyl-modified 1 
residues that are sites of attachment for the fluorescent label): ACA26, AT’*- 
AGCAAAGTCrTACTT*CATCAGACrCAGCCr*T; ACA35, TT'CTTAAA 
CCCAGCrAT*CACAACACATCACAAGCdT*T; and ACA57, GT'GTGT 
CCT GCCAGACr’ACCCTGTTAGAACT'G. A polyclonal rabbit an ti-p^ ' 
coilin antibody was kindly provided by A. Lamond. Nuclear DNA was stained 
with 0.1 pg of 4',6'-diamidlno-2-phenylindole/ml.
RESULTS AND DISCUSSION
Identification of novel human box H/ACA RNAs. From a 
human HeLa cell extract, box H/ACA RNAs were isolated by
'nimunoprecipitation with an antibody directed against the 
GARl box H/ACA RNP protein (16). Since vertebrate box 
H/ACA pseudouridylation guide RNAs are processed from 
Pre-mRNA introns (18, 27), the mature RNAs carry a 5'- 
fcrminal monophosphosphate and a 3'-terminal hydroxyl 
group (31). To facilitate the synthesis of full-length cDNAs, the 
S' and 3' termini of the immunoselected box H/ACA RNAs 
*ere extended by the addition of a phosphorylated oligoribo- 
lucleotide with the help of T4 RNA ligase (Fig. IB). Synthesis 
°f cDNA was performed with avian myeloblastosis virus re­
verse transcriptase and an oligodeoxynucleotide primer com­
plementary to the oligoribonucleotide tag of the template 
RNA. The resulting doubly-tagged cDNA was PCR amplified, 
Inserted into a plasmid vector, and transformed into E. coli. 
About 1,500 individual clones were analyzed by manual or 
automated plasmid sequencing.
We identified a total of 1,120 RNA sequences that defined 
12 previously identified and 61 novel box H/ACA RNAs. As 
demonstrated by computer folding (57), the new RNAs dis­
played all the characteristic hallmarks of box H/ACA RNAs; 
•hey folded into a “hairpin-hinge-hairpin-tail” structure and 
carried H and ACA box motifs (data not shown). Since among 
•he defining structural features of H/ACA RNAs, the presence 
of an ACA motif or, in a few instances, an AUA motif located 
3 nucleotides from the RNA 3' end was noted, the newly 
identified RNAs were designated ACA RNAs and numbered 
from 1 to 61. The expression and size of each RNA were 
confirmed by Northern blot analysis. The majority of recom­
binant plasmids (62%) carried cDNAs of full-length box 
H/ACA RNAs. In a few instances, 5'- and/or 3'-extended 
RNAs that apparently represented processing intermediates of 
mature box H/ACA RNAs were also identified. About one- 
fourth of the recombinant plasmids carried cDNAs corre­
sponding to various fragments of the 18S and 28S rRNAs 
(15%) or representing full-length or partial sequences of the 
5S and 5.8S rRNAs (8%). Less frequently (<2%), we also 
obtained plasmids carrying spliceosomal snRNA, tRNA, and 
mRNA sequences. Although about 20 box H/ACA RNAs were 
highly overrepresented in our cDNA library, we identified the 
sequences of 18 box H/ACA RNAs only once, suggesting that 
°ur survey was not saturated.
The computer-predicted two-dimensional structures of the 
new box H/ACA RNAs were scrutinized to find putative anti- 
sense target recognition elements and eventually to identify 
Potential substrate RNAs. Based on their predicted functions, 
•he new box H/ACA RNAs were divided into three groups. As 
expected, the majority of these RNAs (43 species) have been 
implicated in guiding the pseudouridylation of the 18S or 28S 
rRNAs. Another group of RNAs (6 species) have been as­
signed to the direction of pseudouridine synthesis for the ma­
jor spliceosomal snRNAs. Finally, 12 box H/ACA RNAs clas­
sified in the third group lacked significant complementarities 
•o any known stable cellular RNAs.
Guide RNAs directing the pseudouridylation of 18S rRNA. 
The human 18S rRNA is estimated to contain about 38 
pseudouridine residues, 30 of which have been located either 
exactly or to within 2 or 3 nucleotides (35, 36). Of the newly 
identified box H/ACA RNAs, 19 have been predicted to func- 
•ion in 18S rRNA pseudouridylation (Fig. 2). The potential 
hase-pairing interactions formed between these guide RNAs
and 18S rRNA sequences perfectly conformed to the structural 
requirements defined for efficient RNA-guided pseudouridy­
lation reactions (8, 19, 43). In the pseudouridylation pocket, 
the target uridines occupied an invariant position located 14 or 
15 nucleotides upstream of the H or ACA box of the guide 
RNA.
Based on their predicted target sites, the newly discovered 
18S rRNA-specific pseudouridylation guide RNAs could be 
divided into three groups. For ACA5 (¥1629), ACA8 (¥1060 
and ¥1085), ACA13 (¥1252), ACA20 (¥655), ACA24 
(¥867), ACA25 (¥805 and ¥818), ACA28 (¥819 and ¥870), 
ACA36 (¥109), ACA41 (¥1648), and ACA50 (¥38 and 
¥109), the selected uridines already had been demonstrated to 
be pseudouridylated (35, 36) (Fig. 2A). The base-pairing ca­
pacity of some other guide RNAs, such as ACA5 (¥1242), 
ACA14 (¥970), ACA15 (¥1371), ACA31 (¥222), ACA36 
(¥1248), ACA42 (¥113 and ¥576), ACA44 (¥826), and 
ACA60 (¥1008), could distinguish between two or three pos­
sible pseudouridylation sites that had not been located to nu­
cleotide resolution (36) (Fig. 2B). Finally, the uridine residues 
selected by the ACA4 (U1351), ACA10 (U214), ACA24 
(U613), ACA44 (U690), and ACA46 (U653) putative 
pseudouridylation guide RNAs had not been reported to be 
pseudouridylated (36) (Fig. 2C).
Since not all pseudouridines had been located on the human 
18S rRNA, the state of pseudouridylation of these uridine 
residues was examined by the CMC treatment-primer exten­
sion procedure (5) (Fig. 3). CMC reacts with N3 of pseudouri­
dine, and the modified CMC-pseudouridine arrests reverse 
transcriptase 1 nucleotide before the pseudouridylation site. 
When 32P-labeled sequence-specific oligonucleotides were an­
nealed to CMC-modified 18S rRNA and extended by reverse 
transcriptase, stop signals were observed 1 nucleotide before 
the U1351, U214, U613, U690, and U653 residues, indicating 
that they are pseudouridylated. Primer extension mapping of 
¥690 also revealed that, in contrast to previous reports (35, 
36), neither U692 nor U693 is pseudouridylated in HeLa cell 
18S rRNA. Likewise, mapping of ¥222 showed that the 222- 
UUU-224 region of the human 18S rRNA contains only one 
and not two pseudouridines, as proposed before (35,36). Thus, 
the characterization of new box H/ACA guide RNAs revealed 
new pseudouridylation sites and defined the correct positions 
of several previously detected pseudouridines in the human 
18S rRNA.
Along with the previously characterized U23, U66, U67, 
U69, U70, and U71 snoRNAs (19), thus far 25 human box 
H/ACA guide snoRNAs have been implicated in 18S 
pseudouridylation (see Table SI in the supplemental material). 
These guide RNAs together can define the correct positions of 
33 pseudouridines. Provided that the human 18S rRNA con­
tains a total of 38 pseudouridine residues (39), at this time only 
five pseudouridylation sites lack a potential guide snoRNA. In 
principle, it is possible that some of the pseudouridines missing 
a potential guide RNA, namely, ¥684, ¥922, ¥1178 (36), 
¥1330 (Fig. 3), and one not yet placed, are synthesized by 
protein enzymes. However, it is also possible that pseudouri­
dylation of the human 18S rRNA is achieved entirely by box 
H/ACA snoRNPs.
Pseudouridylation guide RNAs directing the modification of 
28S rRNA. Based on the estimated ratio of its pseudouridine
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intent to its uridine content, the human 28S rRNA was pre­
dicted to carry about 57 pseudouridines (22, 35). Later, primer 
tension mapping located 54 pseudouridines to nucleotide 
resolution on the human 28S rRNA (45). At the outset of this 
study, six human box H/ACA guide snoRNAs (U19, U64, U65 
U68, E2, and E3) had been implicated in the synthesis of nine 
Pseudouridines in 28S rRNA (19) (see Table S2 in the supple­
mental material). Our survey identified 26 additional box 
H/ACA snoRNAs which could be linked to 35 reported 
Pseudouridylation sites in the 28S rRNA (Fig. 4). Another 
snoRNA, ACA61, was predicted to position the U2496 residue 
for pseudouridylation. Indeed, primer extension mapping con­
firmed the presence of a novel pseudouridine at U2496 (Fig. 
3), indicating that ACA61 is a genuine pseudouridylation guide 
RNA. Therefore, in total, 32 human box H/ACA snoRNAs 
have been implicated in 28S rRNA pseudouridylation. These 
guide RNAs can select 44 of the 57 pseudouridylation sites 
Present in the human 28S rRNA (see Table S2 in the supple­
mental material).
In summary, after identification of 56 putative human rRNA 
Pseudouridylation guide RNAs (19; this study), we can at­
tribute box H/ACA RNA-directed modification to 79 of the 
estimated 97 pseudouridylation sites present in the human 18S, 
5.8S, and 28S rRNAs (see Tables SI and S2 in the supplemen­
tal material). Even allowing the possibility that a few ribosomal 
Pseudouridines are still unknown, we can conclude that the 
great majority of pseudouridines carried by the human rRNAs 
are synthesized by box H/ACA RNPs.
Of the 56 guide RNAs implicated in rRNA pseudouridyla­
tion, 22 are capable of directing two independent modification 
reactions. Usually, the two target sites of the “double 
Pseudouridylation guides” are found on the same rRNA and, 
Host frequently, are located close to each other in the primary 
rRNA sequence. The target pseudouridines selected by the 5' 
hairpins of double guides can be located either upstream or 
downstream of the pseudouridylation sites determined by their 
3' hairpins. Less frequently, the 5' and 3' hairpins of a few 
double guides can function in the pseudouridylation of two 
rRNA species. The U69 snoRNA can direct the pseudouridy­
lation of the 18S and 5.8S rRNAs, while the ACA10 and 
ACA31 snoRNAs are predicted to function in the modification 
of the 18S and 28S rRNAs.
Together, the two short helixes formed by the H/ACA guide 
RNA and rRNA sequences preceding and following the target 
uridine comprise a minimum of 9 bp or a maximum of 16 bp 
(Fig. 2 and 4). Most frequently (in 31% of the total instances), 
the rRNA-H/ACA RNA interaction involves 11 bp. In a few 
Instances, mismatched (ACA24, ACA25, ACA15, and 
ACA58) or bulging (ACA41) nucleotides are also involved in 
the predicted rRNA-H/ACA RNA interaction. It is also note-
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FIG. 3. Verification of pseudouridine residues in human 18S and 
28S rRNAs predicted by guide RNA-rRNA interactions. CMC-alkali- 
modified (4') or control (N) HeLa cell RNAs were analyzed by primer 
extension with 32P-labeled oligonucleotide primers complementary to 
the appropriate regions of the human 18S and 28S rRNAs. Lanes A, G, 
C, and U show dideoxy sequencing reactions performed on recombi­
nant plasmids carrying the human I8S or 28S rRNA genes. Brackets 
and asterisks indicate uridines that were reported to be pseudouridy- 
lated.
worthy that G-U base pairs frequently occur in the predicted 
rRNA-H/ACA RNA helices, especially those composed of 
more than 10 bp.
Identification of the ACA2 and ACA34 snoRNAs provided
FIG. 2. Potential base-pairing interactions between box H/ACA RNAs and human 18S rR N A  (A) Selection of known pseudouridylation sites. 
The upper strands represent box H/ACA RNA sequences in a 5’-to-3' orientation. Solid lines represent the upper parts of the 5' or 3' hairpins 
of guide RNAs. The ACA motifs are in closed boxes. The first three nucleotides of the putative H motifs are in open-ended boxes. The lower 
strands represent 18S rRNA sequences in a 3 '-to-5 ' orientation. The positions of pseudouridine residues were reported previously (36). The 
Pseudouridine residues defined by interactions with guide RNAs are indicated (4r). The sequence of human 18S rRNA is from GenBank accession 
number U13369. (B) H/ACA RNAs distinguishing between two or three potential pseudouridylation sites. A bar below rRNA sequences indicates 
that one of the underlined uridines is pseudouridine. (C) Prediction of new pseudouridylation sites. Question marks indicate novel pseudouri­
dylation sites revealed by identification of the corresponding guide RNAs.
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FIG. 4. Potential base-pairing interactions between box H/ACA RNAs and human 28S rRNA. The sequence of human 28S rRNA is fro® 
GenBank accession number U13369. The positions of pseudouridine residues were reported previously (45). See the legend to Fig. 2 for other 
details.
us with new insights into the molecular mechanism of the 
evolution of modification guide RNAs. The ACA34 snoRNA 
and two sequence variants of the ACA2 snoRNA (ACA2a and 
ACA2b) are encoded within three different introns of a hypo­
thetical protein gene, FU20436 (see Table S2 in the supple­
mental material). Interestingly, the ACA34 snoRNA shows a
strong sequence similarity to both isoforms of ACA2 (66°/o 
identity). Therefore, it could be considered a third sequence 
variant of ACA2. Consistent with this notion, the 3' hairpin of 
ACA34, similar to those of ACA2a and ACA2b, can position 
the U4283 residue in the 28S rRNA for pseudouridylation 
(Fig. 4). However, while the 5' hairpins of ACA2a and ACA2b
can direct the synthesis of ¥4264, the 5' hairpin of ACA34 
Elects ¥4270 in the 28S rRNA. Apparently, the ACA2a, 
ACA2b, and ACA34 snoRNA genes have been generated by 
subsequent gene duplications during evolution. After the first 
duplication event, random point mutations in the target rec­
ognition motifs of the ACA34 gene or the parental gene of the 
contemporary ACA2a and ACA2b genes resulted in a novel 
snoRNA gene with new sequence specificity. The second gene 
duplication event generated the current ACA2a and ACA2b 
genes. Of course, random mutations in the ACA2a or ACA2b 
genes may produce another, functionally distinct pseudouridy- 
lation guide RNA gene during future evolution.
Guide RNAs implicated in the pseudouridylation of spliceo- 
soraal snRNAs. The human Ul, U2, U4, U5, and U6 spliceo- 
somal snRNAs together carry 21 pseudouridines (38). Earlier, 
*e characterized four guide RNAs (U85, U89, U92, and U93) 
which were predicted to direct the synthesis of four pseudouri­
dines in the U5 (¥85 and ¥89) and U2 (¥92 and ¥93) 
snRNAs (see Table S3A in the supplemental material). The 
current survey identified six additional box H/ACA RNAs im­
plicated in the pseudouridylation of the U6 (ACA12), U2 
(ACA26, ACA35, and ACA45), U l (ACA47), and U5 
(ACA57) snRNAs (Fig. 5A). Together, the above-described 
H/ACA guide RNAs can direct the synthesis of 11 pseudouri­
dine residues in the Ul, U2, U5, and U6 spliceosomal 
snRNAs. This finding indicates that the involvement of box 
H/ACA guide RNAs in snRNA pseudouridylation is more 
general than demonstrated before. However, at this time, we 
cannot exclude the possibility that protein enzymes also con­
tribute to the pseudouridylation of spliceosomal snRNAs (25, 
37>-Most of the previously identified modification guide RNAs 
implicated in pseudouridylation (U85 and U89) or 2'-0-ribose 
methylation (U87 and U88) of spliceosomal snRNAs are com­
posed of a box H/ACA domain and a box C/D domain (13,25). 
The U93 pseudouridylation guide RNA contains two tandemly 
arranged box H/ACA domains (26). In contrast, the new spli­
ceosomal pseudoridylation guide RNAs, ACA12, ACA26, 
ACA35, ACA45, ACA47, and ACA57, possess the consensus 
hairpin-hinge-hairpin-tail structure of box H/ACA snoRNAs, 
indicating that canonical box H/ACA guide RNAs participate 
in the pseudouridylation of spliceosomal snRNAs more often 
than earlier observations suggested (13).
In human HeLa cells, the formerly characterized pseudouri­
dylation and 2'-0-ribose methylation guide RNAs involved in 
modification of the RNA pol II-transcribed Ul, U2, and U5 
spliceosomal snRNAs were found to specifically accumulate in 
nucleoplasmic Cajal bodies (13,24,26). To further explore the 
subnuclear organization of the modification machinery of pol 
Il-specific snRNAs, we investigated the localization of the 
newly identified ACA26, ACA35, and ACA57 RNAs that were 
implicated in the pseudouridylation of the U2 snRNA. Due to 
the detection limit of fluorescence in situ hydridization, the 
endogenous ACA26, ACA35, and ACA57 RNAs were not 
visible in HeLa cells (data not shown). Therefore, to facilitate 
detection, the ACA26, ACA35, and ACA57 RNAs were tran­
siently overexpressed in HeLa cells by using the pCMV-globin 
expression construct, which had been developed to study the 
expression of intronic snoRNAs (13, 30) (Fig. 5B). Upon hy­
bridization with fluorescent oligonucleotides specific for the
ACA26, ACA35, and ACA57 RNAs, a few bright foci were 
observed in the nuclei of transfected HeLa cells. Staining of 
the same cells with an antibody against the Cajal body marker 
protein, p80-coilin (3), demonstrated that the foci accumulat­
ing the transiently expressed box H/ACA RNAs were Cajal 
bodies. These results further support the notion that the guide 
RNA machinery directing the modification of pol II-tran- 
scribed spliceosomal snRNAs is sequestered in Cajal bodies 
and that Cajal bodies are the nuclear locale for RNA-guided 
modification of pol Il-specific spliceosomal snRNAs (13, 24, 
26).
Putative pseudouridylation guide RNAs lacking substrate 
RNAs. Our screen also identified 12 putative pseudouridyla­
tion guide RNAs which lacked the potential for guiding 
pseudouridine synthesis in human rRNAs, snRNAs, snoRNAs, 
scaRNAs, and YRNAs as well as in the U7,7SK, MRP, RNase 
P, telomerase, and 7SL RNAs (see Table S3B in the supple­
mental material). The function of these so-called “orphan” 
guide RNAs remains unknown. According to the most obvious 
scenario, they may direct pseudouridine formation in some 
not-yet-identified RNAs. Thus, our data indicate that H/ACA 
RNA-directed RNA pseudouridylation is not restricted to rR­
NAs and snRNAs and is a more general phenomenon than 
assumed before. Alternatively, some of the orphan box H/ACA 
RNAs may also function in other aspects of RNA biogenesis. 
For example, the human U17 box H/ACA snoRNA and its 
yeast orthologue, snR30, play an essential role in the nucleo- 
lytic processing of 18S rRNA (4, 41). Likewise, a few box C/D 
snoRNAs play a crucial role in the nucleolytic processing of 
18S (U3, U14, and U22) as well as 5.8S and 28S (U8) rRNAs 
(52). Therefore, it is possible that at least some of the newly 
identified orphan box H/ACA RNAs function in the nucleo­
lytic processing of rRNAs or other cellular RNAs.
Northern blot analysis revealed that, in general, orphan 
H/ACA RNAs accumulate in HeLa cells at much lower levels 
than do snoRNAs involved in rRNA pseudouridylation (data 
not shown). In line with this observation, the majority of the 
new orphan RNAs appeared only once in our screen. This 
finding strongly suggests that the low-abundance orphan 
H/ACA RNAs, in contrast to the abundant rRNA modification 
guide RNAs, are highly underrepresented in our cDNA li­
brary. On the other hand, box H/ACA RNAs may also possess 
a tissue-specific expression pattern. The mouse and human 
HBI-36 snoRNAs that are encoded within introns of the brain- 
specific serotonin receptor gene accumulate only in brain tis­
sues (10). Therefore, it is possible that many additional low- 
abundance and/or tissue-specific box H/ACA RNAs remain 
unidentified in human cells.
Genomic organization of human box H/ACA RNA genes. 
Database searches revealed that the human genome carries 
one perfect and sometimes a few additional imperfect copies of 
the newly identified box H/ACA RNAs (see Tables SI, S2, and 
S3 in the supplemental material). The genomic loci that 
matched perfectly our cDNA sequences were considered bona 
fide H/ACA RNA genes. With no exception, all H/ACA RNA 
genes were found within introns of active transcription units 
known to produce spliced mRNAs. Moreover, all bona fide 
H/ACA RNA genes showed a parallel orientation with their 
host genes, indicating that the H/ACA RNAs and their host 
pre-mRNAs are synthesized cotranscriptionally. The majority
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°f the H/ACA host genes are protein-coding genes, although in 
■Many instances, the functions of their predicted protein prod­
ucts remain unknown. Frequently, two or even more H/ACA 
RNAs are encoded within different introns of the same host 
Sene. For example, the MGC5306 gene, which encodes a hy­
pothetical protein, hosts at least six box H/ACA RNAs (ACA1, 
ACA8, ACA18, ACA25, ACA32, and ACA40) as well as two 
box C/D snoRNAs (mgh28S-2410 and mgh28S-2412) that are 
Predicted to direct 2'-0-ribose methylation of the human 28S 
rRNA at positions C2410 and G2412 (unpublished results).
The rRNA pseudouridylation guide RNA genes are fre­
quently located in ribosomal protein genes or in other genes 
connected to ribosome biogenesis (nucleolin) or protein syn­
thesis (translation initiation and elongation factors and cyto- 
Plamic protein chaperones). Interestingly, the ACA36 and 
ACA56 genes lie within introns of the dyskerin gene, which 
encodes the common pseudouridine synthase of box H/ACA 
RNPs. Another snoRNA, ACA23, is hosted by the importin 7 
Sene, which encodes an import receptor for ribosomal pro­
teins. Collectively, these observations further corroborate the 
notion that cotranscription is an important way of coordinating 
the regulation of factors required for ribosome synthesis and 
function. Therefore, it is possible that at least some of the 
snoRNA host genes that lack a function will be shown to 
Participate in some aspects of protein synthesis. On the other 
hand, there are also a few host genes, for example, the cyto- 
chrome P450 oxidoreductase (ACA14a and ACA14b), methyl- 
CpG binding domain protein 2 (a DNA methyltransferase) 
(ACA37), and SRCAP (a transcriptional activator) (ACA30) 
genes, that cannot be directly linked to ribosome biogenesis or 
function.
Usually, the host genes of H/ACA RNAs directing the 
Pseudouridylation of spliceosomal snRNAs (see Table S3A in 
the supplemental material) or lacking potential substrate 
RNAs (see Table S3B in the supplemental material) cannot be 
directly connected to ribosome biogenesis or translation. The 
ACA33 and ACA51 RNAs represent the only exceptions to 
this rule, since they are encoded within the S12 ribosomal 
Protein and NOP56 box C/D snoRNP protein genes, respec­
tively. The nonribosomal guide RNA genes frequently appear 
"ithin genes encoding proteins involved in the functional 
•Maintenance of the human genome, such as the catalytic sub­
unit of DNA polymerase alpha (ACA12), condensin subunit 1 
(U85), nucleosome assembly protein 1-like protein (ACA54), 
and chromodomain helicase DNA binding protein 4 (ACA57). 
The functional significance of this observation is still unclear.
Several box H/ACA RNAs are encoded within genes that 
have little capacity for protein coding. The spliced and poly- 
adenylated mRNA-like products of these genes contain no 
long open reading frames. Therefore, it appears that the only
function of these genes is to express their intronic H/ACA 
RNAs (53). Of the 75 known human box H/ACA RNA genes, 
15 seem to be located within introns of non-protein-coding 
genes, indicating that cotranscription within non-protein-cod- 
ing pre-mRNAs is a rather common way to express pseudouri­
dylation guide RNAs. Previously, four non-protein-coding 
snoRNA host genes were identified and shown to belong to the 
family of 5'-terminal oligopyrimidine (5 TOP) genes (9,46,51, 
53). The sequence of 5'TOP mRNAs commences with a 5'- 
terminal C residue and is followed by a short pyrimidine tract 
that plays an important role in the upregulation of transcrip­
tion and translation of 5'TOP mRNAs (2). The family of 
5'TOP genes also includes ribosomal protein and translation 
elongation factor genes. The expression of rRNA modification 
guide snoRNAs within non-protein-coding 5'TOP pre-mRNAs 
therefore may provide a regulatory mechanism to coordinate 
the accumulation of snoRNAs and ribosomal proteins. Inspec­
tion of the 5'-terminal sequences of the expressed sequence 
tags of the newly identified non-protein-coding H/ACA 
snoRNA host genes revealed that at least two of them, named 
TOPI (encoding ACA16, ACA44, and ACA61) and TOP2 
(encoding ACA17 and ACA43), belong to the family of 5'TOP 
genes. Unfortunately, the correct 5' ends of other non-protein­
coding H/ACA host genes could not be inferred from their 
partial expressed sequence tags deposited in databases.
Besides the bona fide genes, most box H/ACA RNAs pos­
sess one or more imperfect genomic copies. These defective 
copies often represent 5'- or 3'-truncated versions of the au­
thentic H/ACA RNA gene, indicating that they are apparently 
pseudogenes. Consistent with this conclusion, the sequences of 
the truncated H/ACA genes cannot be folded into the charac­
teristic secondary structures of box H/ACA RNAs. Other 
genomic copies represent full-length H/ACA RNAs, but they 
contain numerous point mutations, short internal deletions, 
and/or insertions. These genomic sequences frequently fail to 
fold into a perfect hairpin-hinge-hairpin-tail structure or lack 
functional H and/or ACA motifs, suggesting that they do not 
code for functional RNAs. Supporting this notion, the default 
H/ACA sequences are frequently located in transcriptionally 
silent genomic loci or, alternatively, lie within known transcrip­
tion units but in an opposite orientation. Both truncated and 
full-length pseudogene sequences are often followed by 8- to 
15-nucleotide-long oligo(A) tracts and sometimes are flanked 
by short perfect repeats, indicating that they have been gener­
ated by retrotransposition (54). Finally, full-length H/ACA 
RNA sequences carrying a few point mutations are also found 
within introns of known genes in a parallel orientation. Since 
the sequences of these genes fold into the hairpin-hinge-hair- 
pin-tail structure, they likely represent functional H/ACA
FIG. 5. Putative pseudouridylation guide RNAs directing the modification of spliceosomal snRNAs. (A) Proposed base-pairing interactions 
between box H/ACA guide RNAs and human spliceosomal snRNAs. (B) Fluorescence in situ localization of guide RNAs transiently overexpressed 
in HeLa cells. The schematic structure of the pCMV-globin expression construct is shown. The promoter region of cytomegalovirus (CMV), the 
exons in the human fi-globin gene (E l to E3), the polyadenylation region in the bovine growth hormone gene (PA), and the SP6 promoter are 
shown. The relevant restriction sites are indicated (H, Hindlll; C, Clal; X,  Xhol). Fluorescence in situ hybridization with oligonucleotide probes 
specific for the ACA26, ACA35, and ACA57 scaRNAs was combined with indirect immunofluorescence with an antibody against the Cajal body 
■Marker protein, p80-coilin. The nuclear DNA was stained with 4',6'-diamidino-2-phenylindole (blue). Bar, 10 p,m. ” v
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RNA genes expressing sequence variants of the characterized 
RNAs.
Conclusions. In this study, we identified 61 human box 
H/ACA snoRNAs and scaRNAs. The majority of these RNAs 
(49 species) are predicted to function as guide RNAs in the 
synthesis of 71 pseudouridine residues in the human 18S and 
28S rRNAs and the Ul, U2, U5, and U6 spliceosomal 
snRNAs. Some of the new H/ACA RNAs (12 species) lack 
potential target sites in human rRNAs, snRNAs, and snoR­
NAs. These orphan H/ACA RNAs either direct the pseudouri- 
dylation of some not-yet-identified RNAs or function in other 
aspects of cellular RNA biogenesis. As predicted by their 
genomic organization, all human box H/ACA RNAs are pro­
cessed from pre-mRNA introns. The host genes of human 
H/ACA RNAs can be divided into three major groups. Most of 
them encode well-characterized proteins that frequently func­
tion in ribosome biogenesis or protein synthesis. Another 
group of H/ACA RNA host genes are predicted to encode 
proteins with unknown functions. Finally, the host genes of 
many H/ACA RNAs lack apparent protein-coding capacity 
and frequently belong to the family of 5'TOP genes.
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Table 1
RNA Length Target Host gene Additional copies Ref. Accession No
18SrRNA
1)23 138 ¥97 nucleolin 4 (20) A3007015
U66 133 ¥123 ribosomal protein L5 - (20) Y11160
1)67 137 ¥1449 eukaryotic translation initiation factor 4A1 3 (20) Y11161
1)69* 132 ¥40 ribosomal protein L39 1 (20) Y11163
U70 135 ¥1698 ribosomal protein LlO 15 (20) Y11164
U71a/b 139 ¥410 spliced ESTs (no  apparent protein) 1 (20) Y11165/6
ACA4 138 ¥1351 eukaryotic translation initiation factor 4A2 - this study A3 609452
ACA5a/b/c 134 ¥1242, ¥1629 hypothetical protein KIAA0948 - this study A3609453
ACA8 139 ¥1060, ¥1085 hypothetical protein MGC5306 3 this study A3609454
ACAlO* 133 ¥214 ribosomal protein S2 1 this study A3609432
ACA13 133 ¥1252 hypothetical protein TlGAl - this study A3609455
ACAl4a/b 134/135 ¥970 P450 (cytochrome) oxidoreductase/TOMM20-PENDiNG 1 this study
A3609456/7
ACA15 133 ¥1371 TCPl, zeta subunit (cytopl. protein chaperone) 3 this study A3609458
ACA20 132 ¥655 t c pI, alpha subunit (cytopl. protein chaperone) 2 this study A3609459
ACA24 131 ¥867, ¥613 spliced ESTs (no apparent protein) 2 this study A3609460
ACA25 134 ¥805, ¥818 hypothetical protein MGC5306 5 this study A3609461
ACA28 127 ¥819, ¥870 eukaryotic translation initiation factor 5 - this study A3609462
ACA31* 130 ¥222 hypothetical protein TPTl 1 this study A3609441
ACA36 132 ¥1248, ¥109 dyskerin 3 this study A3609463
ACA41 132 ¥1648 eukaryotic translation elongation factor 1-beta 1 this study A3609464
ACA42 134 ¥576, ¥113 hypothetical protein KIAA0907 - this study A3609465
ACA44 132 ¥826, ¥690 spliced ESTs (no apparent protein, TOPI) 1 this study A3 609466
ACA46 135 ¥653 hypothetical protein KIAA1007 1 this study A3 609467
ACA50 136 ¥38, ¥109 hypothetical protein KIAA1007 - this study A3609468
ACA60 136 ¥1008 spliced ESTs (no apparent protein) - this study A3609469
5.8S rRNA
1)69* 132 ¥71 ribosomal protein l39 - (20) Y11163
U72 132 ¥57 ribosomal protein L30 5 (20) Y11167
Table 2
RNA Length Target Host Gene Additional Copies Ref. Acc. No
U19 200 ¥3744, ¥3746 U19H noncoding mRNA - (29) X94290
E2 153 ¥3731, ¥3733 ribosomal protein SA Claminin receptor 1) 3 (48) L07383
E3 123 ¥4391 simlar to translation initiation factor 4a 2 3 (48) L07384
U64 134 ¥4976 ribosomal protein S2 - (20) Y11158
U65 137 ¥4374, ¥4428 ribosomal protein L12 - (20) Y11159
U68 134 ¥4394 ribosomal protein Ll8a 2 (20) Y11162
ACAl 130 ¥4442 hypothetical protein MGC5306 4 this study A3609425
ACA2a/b 135/137 ¥4264, ¥4283 hypothetical protein FL320436 - this study A3609426/7
ACA3 130 ¥3900, ¥3939 ribosomal protein L27a 1 this study A3609428
ACA6 149 ¥3617 ribosomal protein SA (laminin receptor 1) - this study A3609429
ACA7 139 ¥1570, ¥1780 ribosomal protein L32 3 this study A3609430
ACA9 133 ¥1671, ¥1770 spliced est (no apparent protein) 3 this study A3609431
ACAlO* 133 ¥4492 ribosomal protein S2 1 this study A3609432
ACA16 134 ¥4413 spliced ESTs (no apparent protein, TOPl) 1 this study A3609433
ACA17 133 ¥4599, ¥4660 spliced ESTs (no apparent protein, TOP2) 1 this study A3609434
ACA19 128 ¥3619, ¥3710 eukaryotic translation initiation factor 3,theta - this study A3609435
ACA21 133 ¥4402, ¥4471 ribosomal protein L23 - this study A3609436
ACA22 134 ¥4967 spliced ESTs (no apparent protein) 3 this study A3609437
ACA23 189 ¥4332, ¥3738 RAN binding protein 7 (importin 7) - this study A3609438
ACA27 126 ¥3695, ¥4523 ribosomal protein L21 3 this study A3609439
ACA30 129 ¥ 4 6 4 4 SRCAP, Snf2-related CBP activator protein 3 this study A3609440
ACA31* 130 ¥3714 hypothetical protein TPTl 1 this study A3609441
ACA32 121 ¥1848 hypothetical protein MGC5306 1 this study A3609442
ACA34 137 ¥4270, ¥4283 hypothetical protein FL320436 2 this study A3609443
ACA37 129 ¥4644 methyl-CpG binding domain protein 2 3 this study A3609444
ACA40 127 ¥4547 hypothetical protein MGC5306 19 this study A3609445
ACA43 136 ¥4938 spliced ESTs (no apparent protein, TOP2) 2 this study A3609446
ACA48 135 ¥3798 eukaryotic translation initiation factor 4Al 8 this study A3609447
ACA52 134 ¥1732 ribosomal protein LP2 - this study A3609448
ACA56 129 ¥1665 dyskerin - this study A3609449
ACA58 137 ¥3824 mitochondrial ribosomal protein L3 2 this study A3609450
ACA61 130 ¥2496 spliced ESTs (no apparent protein, TOPl) - this study A3609451
Table 3
A
RNA Length Target
1)85* 330 U5:^46
1)89* 270 us-.^e
U92 131 U2:'F44,'F34
U93* 275 U2:'F54
ACA12 130 U6:'i,40
ACA26 129 U2:VP41,^39
ACA35 166 U2:'I'89
ACA45 127 l)2:'F37
ACA47 187 Ul:^
ACA57 137 05:^43
B
RNA Length
1)87* 277
1)88* 266
HBI-36 127
1)99 159
U100 140
ACAll 125
ACA18 132
ACA29 140
ACA33 133
ACA38 132
ACA39 136
ACA49 136
ACA51 132
ACA53 250
ACA54 123
ACA55 137
ACA59 152
Host gene Ad
condensin subunit 1 (chromosome condensation)
B-cell receptor associated protein 
hypothetical protein KIAA1574 
spliced ESTs (no apparent protein) 
dna polymerase alfa, catalytic subunit 
hypothetical protein KIAA0907
protein phosphatase 1, regulatory (inhibitor) subunit 8 
spliced ESTs (no apparent protein) 
spliced ESTs (no apparent protein)
similar to chromodomain helicase dna binding protein 4
copies Ref. Acc. No
- (25) AF308283
- (13) AY077739
- (13) AY077742
- (26) AF492209
- this study A3609482
1 this study A3609483
- this study A3609484
2 this study A3609485
5 this study A3609486
2 this study A3609487
Host gene
hypothetical protein FL310035
hypothetical protein FL310035
serotonin receptor (5HT-1C)
hypothetical protein MGC2477
hypothetical protein FL320516
wolf-Hirschhorn syndrome candidate 1 protein
hypothetical protein MGC5306
TCPl alpha subunit (cytopl. protein chaperone)
ribosomal protein S12
HLA-B associated transcript 2 (BAT2 protein)
hypothetical protein LOC128439
ElA binding protein p400
Nop56p (box C/D snoRNA-binding protein)
hypothetical protein SLC25A3
nucleosome assembly protein 1-like 4
poly(A)-binding protein, cytoplasmic 4
hypothetical protein FL310847
copies Ref. Acc. No
3 (13) AY077737
1 (13) AY077738
- (10) AF357423
- (53) AY349600
- (53) AY349601
1 this study A3609470
3 this study A3609471
- this study A3609472
2 this study A3609473
- this study A3609474
- this study A3609475
- this study A3609476
7 this study A3609477
- this study A3609478
- this study A3609479
- this study A3609480
1 this study A3609481
Legends to Supplemental M aterial
Table 1. Compilation of human box H/ACA RNAs predicted to function in pseudouridylation of 18S and 5.8S rRNAs. RNAs also implicated in 
28S rRNA pseudouridylation are indicated by asterisks.
Table 2. Compilation of human box H/ACA RNAs implicated in 28S rRNA pseudouridylation. Asterisks indicate guide RNAs that are predicted to 
function also in 18S rRNA pseudouridylation. The ACA16 RNA, under the name of U98a, has been published as an orphan H/ACA RNA (54).
Table 3. Compilation of human non-ribosomal pseudouridylation guide RNAs. (A) Box H/ACA RNAs directing pseudouridylation of spliceosomal 
snRNAs. (B) Box H/ACA RNAs of unknown function. Asterisks indicate composite H/ACA-C/D (U85, U87, U88 and U89) and H/ACA-H/ACA 
(U93) RNAs.
